Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 07, 2023 | |
Document and Entity Information | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-33892 | |
Entity Registrant Name | AMC ENTERTAINMENT HOLDINGS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-0303916 | |
Entity Address, Address Line One | One AMC Way | |
Entity Address, Address Line Two | 11500 Ash Street | |
Entity Address, City or Town | Leawood | |
Entity Address, State or Province | KS | |
Entity Address, Postal Zip Code | 66211 | |
City Area Code | 913 | |
Local Phone Number | 213-2000 | |
Title of 12(b) Security | Class A common stock | |
Trading Symbol | AMC | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 198,356,898 | |
Entity Central Index Key | 0001411579 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues | ||||
Total revenues | $ 1,405.9 | $ 968.4 | $ 3,708.2 | $ 2,920.5 |
Operating costs and expenses | ||||
Operating expense, excluding depreciation and amortization below | 449.8 | 400.6 | 1,245 | 1,147.6 |
Rent | 224.3 | 223.2 | 650.8 | 668.8 |
General and administrative: | ||||
Merger, acquisition and other costs | 0.7 | 0.3 | 1.5 | 0.4 |
Other, excluding depreciation and amortization below | 54.4 | 40.6 | 184.8 | 161.2 |
Depreciation and amortization | 88.7 | 96.9 | 279.1 | 293 |
Operating costs and expenses | 1,306.5 | 1,083.3 | 3,632.2 | 3,218.4 |
Operating income (loss) | 99.4 | (114.9) | 76 | (297.9) |
Other expense, net: | ||||
Other expense (income) | (12.8) | (1) | (4.7) | 91.6 |
Interest expense: | ||||
Corporate borrowings | 93.4 | 85.1 | 276.1 | 246.6 |
Finance lease obligations | 0.9 | 1 | 2.8 | 3.2 |
Non-cash NCM exhibitor services agreement | 9.4 | 9.6 | 28.5 | 28.6 |
Equity in (earnings) loss of non-consolidated entities | (3.1) | (2.8) | (5.3) | 3.3 |
Investment expense (income) | (3) | 18.3 | (11.4) | 12.2 |
Total other expense, net | 84.8 | 110.2 | 286 | 385.5 |
Net earnings (loss) before income taxes | 14.6 | (225.1) | (210) | (683.4) |
Income tax provision | 2.3 | 1.8 | 4.6 | 2.5 |
Net earnings (loss) | $ 12.3 | $ (226.9) | $ (214.6) | $ (685.9) |
Net earnings (loss) per share: | ||||
Basic (in dollars per share) | $ 0.08 | $ (2.20) | $ (1.43) | $ (6.64) |
Diluted (in dollars per share) | $ 0.08 | $ (2.20) | $ (1.43) | $ (6.64) |
Average shares outstanding: | ||||
Basic (Shares in thousands) | 162,424 | 103,369 | 150,465 | 103,306 |
Diluted (Shares in thousands) | 162,607 | 103,369 | 150,465 | 103,306 |
Admissions | ||||
Revenues | ||||
Total revenues | $ 797.7 | $ 545.3 | $ 2,075.9 | $ 1,640.1 |
Operating costs and expenses | ||||
Operating costs and expenses | 398.5 | 263.2 | 1,027.8 | 781.7 |
Food and beverage | ||||
Revenues | ||||
Total revenues | 482.7 | 333.3 | 1,299.6 | 982.5 |
Operating costs and expenses | ||||
Operating costs and expenses | 90.1 | 58.5 | 243.2 | 165.7 |
Other theatre | ||||
Revenues | ||||
Total revenues | $ 125.5 | $ 89.8 | $ 332.7 | $ 297.9 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) | ||||
Net earnings (loss) | $ 12.3 | $ (226.9) | $ (214.6) | $ (685.9) |
Other comprehensive income (loss): | ||||
Unrealized foreign currency translation adjustments | 9.1 | (26.1) | (38.1) | (78.4) |
Pension adjustments: | ||||
Net gain arising during the period | 0.1 | 0.1 | 0.3 | |
Other comprehensive income (loss) | 9.2 | (26) | (38.1) | (78.1) |
Total comprehensive income (loss) | $ 21.5 | $ (252.9) | $ (252.7) | $ (764) |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 729.7 | $ 631.5 |
Restricted cash | 22.4 | 22.9 |
Receivables, net | 134.2 | 166.6 |
Other current assets | 93.8 | 81.1 |
Total current assets | 980.1 | 902.1 |
Property, net | 1,577.9 | 1,719.2 |
Operating lease right-of-use assets, net | 3,583.5 | 3,802.9 |
Intangible assets, net | 145.5 | 147.3 |
Goodwill | 2,310.8 | 2,342 |
Other long-term assets | 195.3 | 222.1 |
Total assets | 8,793.1 | 9,135.6 |
Current liabilities: | ||
Accounts payable | 236.5 | 330.5 |
Accrued expenses and other liabilities | 342.8 | 364.3 |
Deferred revenues and income | 411 | 402.7 |
Current maturities of corporate borrowings | 20 | 20 |
Current maturities of finance lease liabilities | 6.2 | 5.5 |
Current maturities of operating lease liabilities | 512.3 | 567.3 |
Total current liabilities | 1,528.8 | 1,690.3 |
Corporate borrowings | 4,750.4 | 5,120.8 |
Finance lease liabilities | 48.3 | 53.3 |
Operating lease liabilities | 3,979.7 | 4,252.7 |
Exhibitor services agreement | 492 | 505.8 |
Deferred tax liability, net | 32.8 | 32.1 |
Other long-term liabilities | 99.1 | 105.1 |
Total liabilities | 10,931.1 | 11,760.1 |
Commitments and contingencies | ||
Stockholders' deficit: | ||
Preferred stock | 0.1 | |
Class A common stock ($.01 par value, 550,000,000 shares authorized; 198,356,898 shares issued and outstanding as of September 30, 2023; 524,173,073 authorized; 51,683,892 shares issued and outstanding as of December 31, 2022) | 2 | 0.5 |
Additional paid-in capital | 5,787.6 | 5,049.8 |
Accumulated other comprehensive loss | (115.4) | (77.3) |
Accumulated deficit | (7,812.2) | (7,597.6) |
Total stockholders' deficit | (2,138) | (2,624.5) |
Total liabilities and stockholders' deficit | $ 8,793.1 | $ 9,135.6 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, share authorized (in shares) | 50,000,000 | 50,000,000 |
Class A common stock | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, share authorized (in shares) | 550,000,000 | 524,173,073 |
Common stock, shares issued (in shares) | 198,356,898 | 51,683,892 |
Common stock, shares outstanding (in shares) | 198,356,898 | 51,683,892 |
AMC Preferred Equity Units | ||
Preferred stock, share authorized (in shares) | 0 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 7,245,872 |
Preferred stock, shares outstanding ( in shares) | 0 | 7,245,872 |
Series A Convertible Participating Preferred Stock | ||
Preferred stock, share authorized (in shares) | 0 | 100,000,000 |
Preferred stock, shares issued (in shares) | 72,458,706 | |
Preferred stock, shares outstanding ( in shares) | 0 | 72,458,706 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (214.6) | $ (685.9) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 279.1 | 293 |
(Gain) loss on extinguishment of debt | (97.5) | 96.4 |
Deferred income taxes | 0.8 | 1.1 |
Amortization of net premium on corporate borrowings to interest expense | (42.7) | (48.5) |
Amortization of deferred financing costs to interest expense | 7.1 | 10 |
Non-cash portion of stock-based compensation | 40.9 | 22.3 |
Gain on disposition of Saudi Cinema Company | (15.5) | |
Equity in loss (gain) from non-consolidated entities, net of distributions | (0.9) | 7.8 |
Landlord contributions | 16 | 16.2 |
Other non-cash rent benefit | (27) | (20.6) |
Deferred rent | (97.7) | (130.2) |
Net periodic benefit cost (income) | 1.3 | (0.4) |
Non-cash shareholder litigation expense | 99.3 | |
Change in assets and liabilities: | ||
Receivables | 22.3 | 61.1 |
Other assets | (12.9) | (15.8) |
Accounts payable | (70.5) | (138.9) |
Accrued expenses and other liabilities | (29.9) | (93.1) |
Other, net | (5.8) | 26.9 |
Net cash used in operating activities | (137.4) | (595.2) |
Cash flows from investing activities: | ||
Capital expenditures | (153.5) | (129.7) |
Acquisition of theatre assets | (4) | (17.8) |
Proceeds from disposition of Saudi Cinema Company | 30 | |
Proceeds from disposition of long-term assets | 8.6 | 10.8 |
Proceeds from sale of securities | 11.4 | |
Investments in non-consolidated entities, net | (27.9) | |
Other, net | 2.5 | (0.5) |
Net cash used in investing activities | (116.4) | (153.7) |
Cash flows from financing activities: | ||
Scheduled principal payments under Term Loan due 2026 | (15) | (15) |
Net proceeds from equity issuances | 492.4 | 7.8 |
Principal payments under finance lease obligations | (4.6) | (7.9) |
Cash used to pay for deferred financing costs | (1.8) | (19.3) |
Cash used to pay dividends | (0.7) | |
Taxes paid for restricted unit withholdings | (14.2) | (52.2) |
Net cash provided by (used in) financing activities | 355.3 | (135.5) |
Effect of exchange rate changes on cash and cash equivalents and restricted cash | (3.8) | (30.1) |
Net increase (decrease) in cash and cash equivalents and restricted cash | 97.7 | (914.5) |
Cash and cash equivalents and restricted cash at beginning of period | 654.4 | 1,620.3 |
Cash and cash equivalents and restricted cash at end of period | 752.1 | 705.8 |
Cash paid during the period for: | ||
Interest | 290 | 254.5 |
Income taxes paid, net | 2.8 | 1.1 |
Schedule of non-cash activities: | ||
Investment in NCM | 15 | |
Construction payables at period end | 30.5 | 38.6 |
Other third-party equity issuance costs payable | 0.4 | 3.5 |
Extinguishment of Second Lien Notes due 2026 in exchange for share issuance | 118.6 | |
First Lien Notes due 2029 | ||
Cash flows from financing activities: | ||
Proceeds from issuance of notes | 950 | |
First Lien Notes due 2025 | ||
Cash flows from financing activities: | ||
Principal payments of notes | (500) | |
Premium paid to extinguish notes | (34.5) | |
First Lien Notes due 2026 | ||
Cash flows from financing activities: | ||
Principal payments of notes | (300) | |
Premium paid to extinguish notes | (25.6) | |
First Lien Toggle Notes due 2026 | ||
Cash flows from financing activities: | ||
Principal payments of notes | (73.5) | |
Premium paid to extinguish notes | (14.6) | |
Second Lien Notes due 2026 | ||
Cash flows from financing activities: | ||
Repurchase of Senior Subordinated Debt | (99.8) | (50) |
5.875% Senior Subordinated Notes due 2026 | ||
Cash flows from financing activities: | ||
Repurchase of Senior Subordinated Debt | (1.7) | |
Hycroft | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Unrealized loss (gain) on investments Hycroft | $ 10.8 | $ 3.4 |
BASIS OF PRESENTATION
BASIS OF PRESENTATION | 9 Months Ended |
Sep. 30, 2023 | |
BASIS OF PRESENTATION | |
BASIS OF PRESENTATION | NOTE 1—BASIS OF PRESENTATION AMC Entertainment Holdings, Inc. (“Holdings”), through its direct and indirect subsidiaries, including American Multi-Cinema, Inc. and its subsidiaries, (collectively with Holdings, unless the context otherwise requires, the “Company” or “AMC”), is principally involved in the theatrical exhibition business and owns, operates or has interests in theatres located in the United States and Europe. Stock Split and Reverse Stock Split On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one one Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect both the effects of the special dividend as a stock split and the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares. Liquidity. The Company’s cash burn rates are not sustainable long-term. In order to achieve sustainable net positive operating cash flows and long-term profitability, the Company believes that operating revenues will need to increase to levels in line with pre-COVID operating revenues. North American box office grosses were down approximately 16% for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2019. Until such time as the Company is able to achieve positive operating cash flow, it is difficult to estimate the Company’s liquidity requirements, future cash burn rates, future operating revenues, and attendance levels. Depending on the Company’s assumptions regarding the timing and ability to achieve increased levels of operating revenue, the estimates of amounts of required liquidity vary significantly. There can be no assurance that the operating revenues, attendance levels, and other assumptions used to estimate the Company’s liquidity requirements and future cash burn rates will be correct, and the ability to be predictive is uncertain due to limited ability to predict studio film release dates, the overall production and theatrical release levels, and success of individual titles. Additionally, the effects of labor stoppages, including but not limited to the Writers Guild of America strike that began on May 2, 2023 and ended on September 27, 2023, and the Screen Actors Guild – American Federation of Television and Radio Artists strike that began on July 14, 2023, cannot be reasonably estimated and may have a negative impact on the future film slate for exhibition, the Company’s future liquidity and cash burn rates. Further, there can be no assurances that the Company will be successful in generating the additional liquidity necessary to meet the Company’s obligations beyond twelve months from the issuance of these financial statements on terms acceptable to the Company or at all. The Company may, at any time and from time to time, seek to retire or purchase its outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as it may determine, and will depend on prevailing market conditions, its liquidity requirements, contractual restrictions and other factors. The amounts involved may be material and to the extent equity is used, dilutive. On December 22, 2022, the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Antara Capital LP (“Antara”) pursuant to which the Company agreed to (i) sell to Antara 10,659,511 AMC Preferred Equity Units for an aggregate purchase price of $75.1 million and (ii) simultaneously purchase from Antara $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026 in exchange for 9,102,619 AMC Preferred Equity Units. On February 7, 2023, the Company issued 19,762,130 AMC Preferred Equity Units to Antara in exchange for $75.1 million in cash and $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026. The Company recorded $193.7 million to stockholders’ deficit as a result of the transaction. The Company paid $1.4 million of accrued interest in cash upon exchange of the notes. See Note 7—Stockholders’ Equity for more information. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $114.5 million and paid fees to a sales agent and incurred other third-party issuance costs of approximately $2.9 million and $8.7 million, respectively, through its at-the-market offering of approximately 7.1 million shares of its AMC Preferred Equity Units. The Company paid $11.5 million of other third-party issuance costs during the nine months ended September 30, 2023. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $325.5 million and paid fees to a sales agent and incurred other third-party issuance costs of approximately $8.2 million and $0.5 million, respectively, through its at-the-market offering of 40.0 million shares of its Common Stock. The Company paid $0.1 million of other third-party issuance costs during the nine months ended September 30, 2023. See Note 7—Stockholders’ Equity for further information regarding the at-the-market offerings. The below table summarizes the cash debt repurchase transactions during the nine months ended September 30, 2023, including related party transactions with Antara, which was a related party from February 7, 2023 to August 25, 2023. See Note 6—Corporate Borrowings and Finance Lease Liabilities for more information. Aggregate Principal Reacquisition Gain on Accrued Interest (In millions) Repurchased Cost Extinguishment Paid Related party transactions: Second Lien Notes due 2026 $ 75.9 $ 48.5 $ 40.9 $ 1.1 5.875% Senior Subordinated Notes due 2026 4.1 1.7 2.3 0.1 Total related party transactions 80.0 50.2 43.2 1.2 Non-related party transactions: Second Lien Notes due 2026 89.7 51.3 54.3 2.2 Total non-related party transactions 89.7 51.3 54.3 2.2 Total debt repurchases $ 169.7 $ 101.5 $ 97.5 $ 3.4 Use of Estimates. Principles of Consolidation. Cash and Cash Equivalents. Restricted Cash. Period Ended (In millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 729.7 $ 631.5 Restricted cash 22.4 22.9 Total cash and cash equivalents and restricted cash in the statement of cash flows $ 752.1 $ 654.4 Accumulated Other Comprehensive Loss. Foreign (In millions) Currency Pension Benefits Total Balance December 31, 2022 $ (78.8) $ 1.5 $ (77.3) Other comprehensive loss (38.1) — (38.1) Balance September 30, 2023 $ (116.9) $ 1.5 $ (115.4) Accumulated Depreciation and Amortization. Other Expense (Income). Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Decreases related to contingent lease guarantees $ — $ (0.1) $ — $ (0.2) Governmental assistance due to COVID-19 - International markets — (5.4) — (16.2) Governmental assistance due to COVID-19 - U.S. markets — (1.6) — (2.7) Foreign currency transaction (gains) losses 12.8 6.3 (3.2) 14.7 Non-operating components of net periodic benefit cost (income) 0.5 (0.2) 1.2 (0.4) Gain on extinguishment - Senior Subordinated Notes due 2026 — — (2.3) — Loss on extinguishment - First Lien Notes due 2025 — — — 47.7 Loss on extinguishment - First Lien Notes due 2026 — — — 54.4 Loss on extinguishment - First Lien Toggle Notes due 2026 — — — 32.9 Gain on extinguishment - Second Lien Notes due 2026 (10.8) — (95.2) (38.6) Derivative stockholder settlement — — (14.0) — Shareholder litigation (15.3) — 110.1 — Business interruption insurance recoveries — — (1.3) — Total other expense (income) $ (12.8) $ (1.0) $ (4.7) $ 91.6 Accounting Pronouncements Recently Adopted Reference Rate Reform. |
LEASES
LEASES | 9 Months Ended |
Sep. 30, 2023 | |
LEASES | |
LEASES | NOTE 2—LEASES The Company leases theatres and equipment under operating and finance leases. The Company typically does not believe that exercise of the renewal options is reasonably certain at the lease commencement and, therefore, considers the initial base term as the lease term. Lease terms vary but generally the leases provide for fixed and escalating rentals, contingent escalating rentals based on the Consumer Price Index and other indexes not to exceed certain specified amounts and variable rentals based on a percentage of revenues. The Company often receives contributions from landlords for renovations at existing locations. The Company records the amounts received from landlords as an adjustment to the right-of-use asset and amortizes the balance as a reduction to rent expense over the base term of the lease agreement. Equipment leases primarily consist of sight and sound and food and beverage equipment. The Company received rent concessions from lessors that aided in mitigating the economic effects of COVID-19 during the pandemic. These concessions primarily consisted of rent abatements and the deferral of rent payments. Deferred lease payments were approximately $74.2 million as of September 30, 2023. In instances where there were no substantive changes to the lease terms, i.e., modifications that resulted in total payments of the modified lease being substantially the same or less than the total payments of the existing lease, the Company elected the relief as provided by the FASB staff related to the accounting for certain lease concessions. The Company elected not to account for these concessions as a lease modification, and therefore the Company has remeasured the related lease liability and right-of-use asset but did not reassess the lease classification or change the discount rate to the current rate in effect upon the remeasurement. The deferred lease payments have been recorded in the Company’s lease liabilities to reflect the change in the timing of payments. Those leases that did not meet the criteria for treatment under the FASB relief were evaluated as lease modifications. The deferred payment amounts for contractual rent amounts due and not paid are included in accounts payable in the condensed consolidated balance sheets and in change in accounts payable in the condensed consolidated statements of cash flows. In addition, the Company included deferred lease payments in operating lease right-of-use assets as a result of lease remeasurements. A summary of deferred payment amounts related to rent obligations for which payments were deferred to future periods is provided below: As of As of December 31, Decrease September 30, (In millions) 2022 in deferred amounts 2023 Fixed operating lease deferred amounts $ 150.3 $ (80.0) $ 70.3 Finance lease deferred amounts 0.9 (0.7) 0.2 Variable lease deferred amounts 6.0 (2.3) 3.7 Total deferred lease amounts $ 157.2 $ (83.0) $ 74.2 (1) During the nine months ended September 30, 2023, the decrease in fixed operating lease deferred amounts includes $13.3 million of rent payments that are included in change in accounts payable and $66.7 million included in deferred rent and other non-cash rent in the condensed consolidated statement of cash flows. The following table reflects the lease costs for the periods presented: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (In millions) Consolidated Statements of Operations 2023 2022 2023 2022 Operating lease cost Theatre properties Rent $ 201.3 $ 202.0 $ 587.5 $ 608.9 Theatre properties Operating expense 0.6 1.5 1.2 4.1 Equipment Operating expense 4.8 2.7 11.8 7.4 Office and other General and administrative: other 1.3 1.3 4.0 4.0 Finance lease cost Amortization of finance lease assets Depreciation and amortization 0.5 0.6 1.5 2.0 Interest expense on lease liabilities Finance lease obligations 0.9 0.9 2.8 3.1 Variable lease cost Theatre properties Rent 23.0 21.2 63.3 59.9 Equipment Operating expense 17.9 13.4 51.6 44.8 Total lease cost $ 250.3 $ 243.6 $ 723.7 $ 734.2 Cash flow and supplemental information is presented below: Nine Months Ended September 30, September 30, (In millions) 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in finance leases $ (2.3) $ (2.9) Operating cash flows used in operating leases (742.5) (775.9) Financing cash flows used in finance leases (4.6) (7.9) Landlord contributions: Operating cashflows provided by operating leases 16.0 16.2 Supplemental disclosure of noncash leasing activities: Right-of-use assets obtained in exchange for new operating lease liabilities 111.4 220.8 (1) Includes lease extensions and option exercises. The following table represents the weighted-average remaining lease term and discount rate as of September 30, 2023: As of September 30, 2023 Weighted Average Weighted Average Remaining Discount Lease Term and Discount Rate Lease Term (years) Rate Operating leases 8.9 10.4% Finance leases 13.4 6.4% Minimum annual payments, including deferred lease payments and excluding contractual rent amounts due and not paid that were recorded in accounts payable, that are recorded as operating and finance lease liabilities and the net present value thereof as of September 30, 2023 are as follows: Operating Lease Finance Lease (In millions) Payments (2) Payments (2) Three months ending December 31, 2023 $ 241.7 2.2 2024 891.2 8.1 2025 847.1 7.4 2026 781.7 7.3 2027 717.1 7.3 2028 633.5 6.9 Thereafter 2,736.9 44.4 Total lease payments 6,849.2 83.6 Less imputed interest (2,357.2) (29.1) Total operating and finance lease liabilities, respectively $ 4,492.0 $ 54.5 (1) The minimum annual payments table above does not include contractual cash rent amounts that were due and not paid, which are recorded in accounts payable as shown below, including estimated repayment dates: Accounts Payable (In millions) Lease Payments Three months ended December 31, 2023 $ 5.7 2024 1.0 2025 0.8 2026 0.7 2027 0.3 2028 0.1 Thereafter 0.1 Total deferred lease amounts recorded in accounts payable $ 8.7 (2) The minimum annual payments table above includes deferred undiscounted cash rent amounts that were due and not paid related to operating and finance leases, as shown below: Operating Lease Finance Lease (In millions) Payments Payments Three months ended December 31, 2023 $ 15.6 $ 0.1 2024 15.6 — 2025 5.7 — 2026 4.2 — 2027 3.4 — 2028 3.2 — Thereafter 17.7 — Total deferred lease amounts $ 65.4 $ 0.1 As of September 30, 2023, the Company had signed additional operating lease agreements for five theatres that have not yet commenced with total minimum payments of approximately $78.2 million, which are expected to commence between years 2023 and 2025 and carry lease terms ranging from 10 to 20 years. The timing of lease commencement is dependent on the landlord providing the Company with control and access to the related facility. During the nine months ended September 30, 2023, the Company received a $13.0 million buyout incentive from a landlord which provided the landlord the right to terminate the lease of one theatre. The incentive was treated as a reduction to rent expense in the Company’s condensed consolidated statement of operations. |
REVENUE RECOGNITION
REVENUE RECOGNITION | 9 Months Ended |
Sep. 30, 2023 | |
REVENUE RECOGNITION | |
REVENUE RECOGNITION | NOTE 3—REVENUE RECOGNITION Disaggregation of Revenue. Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Major revenue types Admissions $ 797.7 $ 545.3 $ 2,075.9 $ 1,640.1 Food and beverage 482.7 333.3 1,299.6 982.5 Other theatre: Screen advertising 33.2 29.0 96.4 90.2 Other 92.3 60.8 236.3 207.7 Other theatre 125.5 89.8 332.7 297.9 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Timing of revenue recognition Products and services transferred at a point in time $ 1,299.3 $ 884.5 $ 3,431.5 $ 2,675.3 Products and services transferred over time 106.6 83.9 276.7 245.2 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 (1) Amounts primarily include subscription and advertising revenues. The following tables provide the balances of receivables, net and deferred revenues and income: (In millions) September 30, 2023 December 31, 2022 Current assets Receivables related to contracts with customers $ 54.4 $ 92.3 Miscellaneous receivables 79.8 74.3 Receivables, net $ 134.2 $ 166.6 (In millions) September 30, 2023 December 31, 2022 Current liabilities Deferred revenues related to contracts with customers $ 405.7 $ 398.8 Miscellaneous deferred income 5.3 3.9 Deferred revenues and income $ 411.0 $ 402.7 The significant changes in contract liabilities with customers included in deferred revenues and income are as follows: Deferred Revenues Related to Contracts (In millions) with Customers Balance December 31, 2022 $ 398.8 Cash received in advance 248.5 Customer loyalty rewards accumulated, net of expirations: Admission revenues 17.4 Food and beverage 31.6 Other theatre (0.7) Reclassification to revenue as the result of performance obligations satisfied: Admission revenues (197.8) Food and beverage (58.7) Other theatre (33.9) Foreign currency translation adjustment 0.5 Balance September 30, 2023 $ 405.7 (1) Includes movie tickets, food and beverage, gift cards, exchange tickets, and AMC Stubs® loyalty membership fees. (2) Amount of rewards accumulated, net of expirations, that are attributed to AMC Stubs® and other loyalty programs. (3) Amount of rewards redeemed that are attributed to gift cards, exchange tickets, movie tickets, AMC Stubs® loyalty programs and other loyalty programs. (4) Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, AMC Stubs® loyalty membership fees and other loyalty programs. The significant changes to contract liabilities included in the exhibitor services agreement in the condensed consolidated balance sheets, are as follows: Exhibitor Services (In millions) Agreement (1) Balance December 31, 2022 $ 505.8 Reclassification, net of adjustments, for portion of the beginning balance to other theatre revenue, as the result of performance obligations satisfied (13.8) Balance September 30, 2023 $ 492.0 (1) Represents the carrying amount of the National CineMedia, LLC (“NCM”) common units that were previously received under the annual Common Unit Adjustment (“CUA”) and subsequent adjustments related to the NCM Bankruptcy, as discussed in greater detail below. The deferred revenues are being amortized to other theatre revenues over the remainder of the 30-year term of the Exhibitor Service Agreement (“ESA”) ending in February 2037. NCM Bankruptcy Gift Cards and Exchange Tickets. Loyalty Programs. The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. |
GOODWILL
GOODWILL | 9 Months Ended |
Sep. 30, 2023 | |
GOODWILL. | |
GOODWILL | NOTE 4—GOODWILL U.S. Markets International Markets Consolidated Goodwill (In millions) Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Balance December 31, 2022 $ 3,072.6 $ (1,276.1) $ 1,796.5 $ 1,521.8 $ (976.3) $ 545.5 $ 4,594.4 $ (2,252.4) $ 2,342.0 Currency translation adjustment — — — (23.6) (7.6) (31.2) (23.6) (7.6) (31.2) Balance September 30, 2023 $ 3,072.6 $ (1,276.1) $ 1,796.5 $ 1,498.2 $ (983.9) $ 514.3 $ 4,570.8 $ (2,260.0) $ 2,310.8 |
INVESTMENTS
INVESTMENTS | 9 Months Ended |
Sep. 30, 2023 | |
INVESTMENTS | |
INVESTMENTS | NOTE 5—INVESTMENTS Investments in non-consolidated affiliates and certain other investments accounted for under the equity method generally include all entities in which the Company or its subsidiaries have significant influence, but not more than 50% voting control, and are recorded in the condensed consolidated balance sheets in other long-term assets. On December 30, 2022, the Company entered into an agreement to sell its 10.0% investment in Saudi Cinema Company, LLC for SAR 112.5 million ($30.0 million), and on January 24, 2023, the Saudi Ministry of Commerce recorded the sale of equity and the Company received the proceeds on January 25, 2023. The Company recorded a gain on the sale of $15.5 million in investment income during the nine months ended September 30, 2023. Investments in non-consolidated affiliates as of September 30, 2023 include interests in Digital Cinema Distribution Coalition, LLC of 14.6%, AC JV, LLC, owner of Fathom Events, of 32.0%, SV Holdco LLC, owner of Screenvision, of 18.4% and Digital Cinema Media Ltd. of 50.0%. The Company also has partnership interests in four U.S. motion picture theatres and approximately 50.0% interests in 60 theatres in Europe. Indebtedness held by equity method investees is non-recourse to the Company. During the three months ended September 30, 2023 and September 30, 2022, the Company recorded equity in (earnings) loss of non-consolidated entities of $(3.1) million and $(2.8) million, respectively. During the nine months ended September 30, 2023 and September 30, 2022, the Company recorded equity in (earnings) loss of $(5.3) million and $3.3 million, respectively. Related Party Transactions with Equity Method Investees. Investment in Hycroft On March 14, 2022, the Company purchased 23.4 million units of Hycroft Mining Holding Corporation (NASDAQ: HYMC) (“Hycroft”), for $27.9 million, with each unit consisting of one common share of Hycroft and one common share purchase warrant. The units were priced at $1.193 per unit. Each warrant is exercisable for one common share of Hycroft at a price of $1.068 per share over a 5-year — |
CORPORATE BORROWINGS AND FINANC
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES | 9 Months Ended |
Sep. 30, 2023 | |
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES | |
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES | NOTE 6—CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES A summary of the carrying value of corporate borrowings and finance lease liabilities is as follows: (In millions) September 30, 2023 December 31, 2022 First Lien Secured Debt: Senior Secured Credit Facility-Term Loan due 2026 (8.427% as of September 30, 2023 and 7.274% as of December 31, 2022) $ 1,910.0 $ 1,925.0 12.75% Odeon Senior Secured Notes due 2027 400.0 400.0 7.5% First Lien Notes due 2029 950.0 950.0 Second Lien Secured Debt: 10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 1,124.2 1,389.8 Subordinated Debt: 6.375% Senior Subordinated Notes due 2024 (£4.0 million par value as of September 30, 2023) 4.9 4.8 5.75% Senior Subordinated Notes due 2025 98.3 98.3 5.875% Senior Subordinated Notes due 2026 51.5 55.6 6.125% Senior Subordinated Notes due 2027 125.5 125.5 Total principal amount of corporate borrowings $ 4,664.4 $ 4,949.0 Finance lease liabilities 54.5 58.8 Deferred financing costs (33.0) (37.9) Net premium 139.0 229.7 Total carrying value of corporate borrowings and finance lease liabilities $ 4,824.9 $ 5,199.6 Less: Current maturities of corporate borrowings (20.0) (20.0) Current maturities of finance lease liabilities (6.2) (5.5) Total noncurrent carrying value of corporate borrowings and finance lease liabilities $ 4,798.7 $ 5,174.1 (1) The following table provides the net premium (discount) amounts of corporate borrowings: September 30, December 31, (In millions) 2023 2022 10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 $ 170.4 $ 265.5 Senior Secured Credit Facility-Term Loan due 2026 (3.7) (4.8) 12.75% Odeon Senior Secured Notes due 2027 (27.7) (31.1) 6.375% Senior Subordinated Notes due 2024 — 0.1 Net premium $ 139.0 $ 229.7 The following table provides the principal payments required and maturities of corporate borrowing as of September 30, 2023: Principal Amount of Corporate (In millions) Borrowings Three months ended December 31, 2023 $ 5.0 2024 24.9 2025 118.3 2026 3,040.7 2027 525.5 2028 — Thereafter 950.0 Total $ 4,664.4 Debt Repurchases The below table summarizes the cash debt repurchase transactions during the nine months ended September 30, 2023, including the related party transactions with Antara, which was a related party from February 7, 2023 to August 25, 2023: Aggregate Principal Reacquisition Gain on Accrued Interest (In millions) Repurchased Cost Extinguishment Paid Related party transactions: Second Lien Notes due 2026 $ 75.9 $ 48.5 $ 40.9 $ 1.1 5.875% Senior Subordinated Notes due 2026 4.1 1.7 2.3 0.1 Total related party transactions 80.0 50.2 43.2 1.2 Non-related party transactions: Second Lien Notes due 2026 89.7 51.3 54.3 2.2 Total non-related party transactions 89.7 51.3 54.3 2.2 Total debt repurchases $ 169.7 $ 101.5 $ 97.5 $ 3.4 See Note 7—Stockholders’ Equity for discussion of the $100.0 million aggregate principal amount of Second Lien Notes due 2026 repurchased from Antara in exchange for 9,102,619 AMC Preferred Equity Units not included in the table above. Financial Covenants The Company believes its existing cash and cash equivalents, together with cash generated from operations, will be sufficient to comply with the minimum liquidity covenant requirement under its Senior Secured Revolving Credit Facility through the end of the covenant suspension period. Pursuant to the Twelfth Amendment to the Credit Agreement, the requisite revolving lenders party thereto agreed to extend the suspension period for the secured leverage ratio financial covenant applicable to the Senior Secured Revolving Credit Facility under the Credit Agreement through March 31, 2024. The current maturity date of the Senior Secured Revolving Credit Facility is April 22, 2024. The financial covenant applicable to the Senior Secured Revolving Credit Facility is tested as of the last day of any fiscal quarter for which financial statements have been (or were required to have been) delivered, thus the financial covenant has been effectively suspended through maturity of the Senior Secured Revolving Credit Facility. As of September 30, 2023, the Company was subject to a minimum liquidity requirement of $100 million as a condition to the financial covenant suspension period under the Credit Agreement. Thirteenth Amendment to Credit Agreement On June 23, 2023, the Company and Wilmington Savings Fund Society, FSB, as administrative agent, entered into the Thirteenth Amendment to the Credit Agreement, pursuant to which LIBOR, the benchmark rate upon which certain loans, commitments and/or other extensions of credit under the Credit Agreement incur interest, fees or other amounts, was replaced with Term SOFR, a benchmark rate reported by CME Group Benchmark Administration Limited that is based on the secured overnight financing rate. Term SOFR under the Credit Agreement is subject to a credit spread adjustment equal to 0.11448% per annum, 0.26161% per annum, and 0.42826% per annum for interest periods of one-month, three-months, or six-months or longer, respectively. The Thirteenth Amendment to the Credit Agreement became effective at 5:00 p.m. (New York time) on June 30, 2023. The Company elected to apply the optional expedients allowed under ASC 848 regarding the discontinuation of LIBOR and reference rate reform. Pursuant to ASC 848, the Thirteenth Amendment to the Credit Agreement was determined to be an insubstantial modification. |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 9 Months Ended |
Sep. 30, 2023 | |
STOCKHOLDERS' EQUITY | |
STOCKHOLDERS' EQUITY | NOTE 7—STOCKHOLDERS’ EQUITY Stock Split and Reverse Stock Split On August 4, 2022, the Company announced that its Board of Directors declared a special dividend of one AMC Preferred Equity Unit for each share of Common Stock outstanding at the close of business on August 15, 2022, the record date. The dividend was paid at the close of business on August 19, 2022 to investors who held Common Stock as of August 22, 2022, the ex-dividend date. Due to the characteristics of the AMC Preferred Equity Units, the special dividend had the effect of a stock split pursuant to ASC 505-20-25-4. On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one one Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect both the effects of the special dividend as a stock split and the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares. Share Issuances On September 6, 2023, the Company entered into a Common Stock equity distribution agreement (the “Common Stock Equity Distribution Agreement”) with Citigroup Global Markets, Inc., Barclays Capital Inc., B. Riley Securities, Inc. and Goldman Sachs & Co. LLC, as the sales agents (“Common Stock Sales Agents”), to sell up to 40.0 million shares of the Company’s Common Stock, from time to time, through an “at-the-market” offering program (the “Common Stock Offering”). Subject to the terms and conditions of the Common Stock Equity Distribution Agreement, the Common Stock Sales Agents will use reasonable efforts consistent with their normal trading and sales practices, applicable law and regulations, and the rules of the NYSE to sell Common Stock from time to time based upon the Company’s instructions for the sales, including any price, time or size limits specified by the Company. The Company intends to use the net proceeds from the sale of Common Stock pursuant to the Common Stock Equity Distribution Agreement to repay, refinance, redeem or repurchase the Company’s existing indebtedness (including expenses, accrued interest and premium, if any) and otherwise for general corporate purposes. On September 13, 2023, the Company announced that it had completed the Common Stock Offering. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $325.5 million and paid fees to the Common Stock Sales Agents and incurred other third-party issuance costs of approximately $8.2 million and $0.5 million, respectively, through its Common Stock Offering of 40.0 million shares of its Common Stock. The Company paid $0.1 million of other third-party issuance costs during the nine months ended September 30, 2023. On September 26, 2022, the Company entered into an equity distribution agreement (the “Preferred Equity Units Equity Distribution Agreement”) with Citigroup Global Markets Inc., as a sales agent (“Sales Agent”), to sell up to 42.5 million shares of the Company’s AMC Preferred Equity Units, from time to time, through an “at-the-market” offering program (the “Preferred Equity Offering”). Subject to the terms and conditions of the Preferred Equity Units Equity Distribution Agreement, the Sales Agent was required to use reasonable efforts consistent with their normal trading and sales practices, applicable law and regulations, and the rules of the NYSE to sell the AMC Preferred Equity Units from time to time based upon the Company’s instructions for the sales, including any price, time or size limits specified by the Company. The Company intends to use the net proceeds, from the sale of AMC Preferred Equity Units pursuant to the Preferred Equity Units Equity Distribution Agreement to repay, refinance, redeem or repurchase the Company’s existing indebtedness (including expenses, accrued interest and premium, if any) and otherwise for general corporate purposes. Following the Charter Amendments and AMC Preferred Equity Unit Conversion, the Company no longer sells shares under the Preferred Equity Units Distribution Agreement. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $114.5 million and paid fees to the Sales Agent and incurred other third-party issuance costs of approximately $2.9 million and $8.7 million, respectively, through its Preferred Equity Offering of approximately 7.1 million shares of its AMC Preferred Equity Units. The Company paid $11.5 million of other third-party issuance costs during the nine months ended September 30, 2023. The Company no longer has any authorized AMC Preferred Equity Units available for issuance under the Preferred Equity Units Equity Distribution Agreement. Furthermore, the AMC Preferred Equity Units ceased trading on the NYSE on August 24, 2023 and were converted to Common Shares on August 25, 2023. On December 22, 2022, the Company entered into the Forward Purchase Agreement with Antara pursuant to which the Company agreed to (i) sell to Antara 10,659,511 AMC Preferred Equity Units for an aggregate purchase price of $75.1 million and (ii) simultaneously purchase from Antara $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026 in exchange for 9,102,619 AMC Preferred Equity Units. On February 7, 2023, the Company issued 19,762,130 AMC Preferred Equity Units to Antara in exchange for $75.1 million in cash and $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026. The Company recorded $193.7 million to stockholders’ deficit as a result of the transaction. The Company paid $1.4 million of accrued interest in cash upon exchange of the notes. Special Meeting of Stockholders The Company’s board of directors called a special meeting of the Company’s stockholders on March 14, 2023 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved the following proposals: 1. Proposal No. 1: To approve an amendment to our Third Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) to increase the total number of authorized shares of Common Stock from 524,173,073 shares of Common Stock to 550,000,000 shares of Common Stock (the “Share Increase”); 2. Proposal No. 2: To approve an amendment to our Certificate of Incorporation to effectuate a reverse stock split at a ratio of one share of Common Stock for every ten shares of Common Stock, which together with the Share Increase, shall permit the full conversion of all outstanding shares of Series A Preferred Stock into shares of Common Stock (the “Reverse Stock Split” and collectively with the Share Increase, the “Charter Amendments”); and 3. Proposal No. 3: To approve one or more adjournments of the Special Meeting, if necessary, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting to approve and adopt the Charter Amendments. Each of the Share Increase and the Reverse Stock Split were cross-conditioned on the approval of the other, such that approval of both proposals was required for each of them to take effect. Shareholder Litigation Two putative stockholder class actions were filed in the Delaware Chancery Court that assert a breach of fiduciary duty against certain of the Company’s directors and a claim for breach of 8 Del. C This litigation prevented the Company from immediately implementing the Charter Amendments. On April 2, 2023, the parties entered into a binding settlement term sheet to settle the litigation and allow implementation of the Charter Amendments. On August 11, 2023, the Delaware Chancery Court approved the settlement and on Monday, August 21, 2023, the Delaware Supreme Court confirmed the ruling of the Chancery Court. Pursuant to the settlement term sheet, record holders of Common Stock at the close of business on August 24, 2023, after giving effect to the Reverse Stock Split, but prior to the conversion of AMC Preferred Equity Units into Common Stock (“Settlement Payment Recipients”), received a payment of one Charter Amendments and AMC Preferred Equity Unit Conversion Each AMC Preferred Equity Unit was a depositary share and represented an interest in a share of Series A Convertible Participating Preferred Stock evidenced by a depositary receipt pursuant to a deposit agreement. Each AMC Preferred Equity Unit was designed to have the same economic and voting rights as a share of Common Stock. On August 14, 2023, the Company filed an amendment to its Certificate of Incorporation to effectuate the Charter Amendments as of August 24, 2023. The Charter Amendments permitted the conversion of all of the Company’s outstanding AMC Preferred Equity Units into shares of Common Stock (the “Conversion”). On August 25, 2023, 99,540,642 shares of Common Stock were issued as part of the Conversion. On August 25, 2023, AMC Preferred Equity Units ceased trading and were subsequently delisted from the NYSE. On August 25, 2023, the Company filed a Certificate of Elimination of Series A Convertible Participating Preferred Stock with the Secretary of State of Delaware that eliminated the Series A Convertible Participating Preferred Stock from the Company’s Certificate of Incorporation. As of September 30, 2023, the Company has 50,000,000 authorized shares of preferred stock. AMC’s Board of Directors approved equitable adjustments to all outstanding awards under the 2013 Equity Incentive Plan subsequent to the effectiveness of the Charter Amendments. The outstanding awards were proportionally adjusted consistent with the ratio used for the Reverse Stock Split and all awards previously convertible into AMC Preferred Equity Units are now convertible into Common Stock. Stock-Based Compensation The following table presents the stock-based compensation expense recorded within general and administrative: other: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (In millions) 2023 2022 2023 2022 Equity classified awards: Special awards expense $ — $ — $ 20.2 $ — Board of director stock award expense — — 0.9 0.8 Restricted stock unit expense 3.7 3.5 10.5 9.8 Performance stock unit expense 3.6 (7.1) 9.0 11.7 Total equity classified awards: 7.3 (3.6) 40.6 22.3 Liability classified awards: Restricted and performance stock unit expense (0.1) — 0.3 — Total liability classified awards: (0.1) — 0.3 — Total stock-based compensation expense $ 7.2 $ (3.6) $ 40.9 $ 22.3 As of September 30, 2023, the estimated remaining unrecognized compensation cost related to stock-based compensation grants was approximately $20.1 million, which reflects assumptions related to attainment of performance targets based on the scales as described below. The weighted average period over which this remaining compensation expense is expected to be recognized is approximately 1.1 years. Plan Amendment due to Stock Split The 2013 Plan contemplates equitable adjustments for certain transactions such as a stock split. On August 19, 2022, the Compensation Committee approved an adjustment to the 2013 Equity Incentive Plan to entitle each participant one AMC Preferred Equity Unit and one share of Common Stock for each restricted stock unit (“RSU”) or performance stock unit (“PSU”) for awards granted prior to the AMC Preferred Equity Unit special dividend. The Company determined that this modification was a Type 1 (probable-to-probable) modification that did not increase the fair value of the award and therefore did not require additional stock-based compensation expense to be recognized. Special Awards On February 23, 2023, AMC’s Board of Directors approved special awards in lieu of vesting of the 2022 PSU awards. The special awards were accounted for as modification to the 2022 PSU awards which lowered the Adjusted EBITDA and free cash flow performance targets such that 200% vesting was achieved for both tranches. This modification resulted in the immediate additional vesting of 238,959 Common Stock 2022 PSUs and 238,959 AMC Preferred Equity Unit 2022 PSUs. This was treated as a Type 3 modification (improbable-to-probable) which requires the Company to recognize additional stock compensation expense based on the modification date fair values of the Common Stock PSUs and AMC Preferred Equity Units PSUs of $14.9 million and $5.3 million, respectively. During the nine months ended September 30, 2023, the Company recognized $20.2 million of stock compensation expense related to these awards. Awards Granted in 2023 During the nine months ended September 30, 2023, AMC’s Board of Directors approved awards of stock, RSUs, and PSUs to certain of the Company’s employees and directors under the 2013 Equity Incentive Plan. Each RSU or PSU is convertible into one share of Common Stock upon vesting. Each RSU and PSU held by a participant as of a dividend record date is entitled to a dividend equivalent equal to the amount paid with respect to one share of Common Stock underlying the unit. Any such accrued dividend equivalents are paid to the holder only upon vesting of the units. Each unit represents the right to receive one share of Common Stock at a future date. The Company’s Board of Directors also granted awards to non-section 16 officers that are expected to be settled in cash. Upon vesting, participants receiving cash settlement shall receive an amount of cash equal to the closing price of an AMC Preferred Equity Unit multiplied by the number of underlying cash-based RSUs and PSUs awarded. Following the completion of the Charter Amendments, grantees will now receive an amount of cash equal to the closing price of Common Stock multiplied by the number of underlying cash-based RSUs and PSUs award. These awards have been classified as liabilities and are included within accrued expenses and other liabilities in the condensed consolidated balance sheets. The vesting requirements and vesting periods are identical to the equity classified awards described below. The Company recognizes expense related to these awards based on the fair value of the Common Stock shares, giving effect to the portion of services rendered during the requisite services period. As of September 30, 2023, there were 169,401 nonvested underlying Common Stock RSUs and PSUs related to awards granted to non-section 16 officers. There are 112,894 nonvested underlying Common Stock RSUs and PSUs (2023 Tranche Year) that are currently classified as liabilities and 56,507 nonvested underlying Common Stock PSUs (2024 & 2025 Tranche Year) which have not been granted for accounting purposes as the performance targets for the 2024 and 2025 PSU Tranche Years have yet to be established. The 2023 award agreements generally had the following features: ● Stock Award Agreement: During the nine months ended September 30, 2023, the Company granted awards of 8,555 fully vested shares of Common Stock and 15,370 AMC Preferred Equity Units to its independent members of AMC’s Board of Directors with a grant date fair value of $0.9 million. ● Restricted Stock Unit Award Agreement: During the nine months ended September 30, 2023, the Company granted 313,831 RSU awards to certain members of management with a grant date fair value of $12.0 million. The Company records stock-based compensation expense on a straight-line recognition method over the requisite vesting period. The RSUs vest over three years , with one-third vesting each year. These RSUs will be settled within 30 days of vesting. ● Performance Stock Unit Award Agreement: During the nine months ended September 30, 2023, total PSUs of 287,664 were awarded (“2023 PSU award”) to certain members of management and executive officers, with the total PSUs divided into three separate year tranches, with each tranche allocated to a fiscal year within the performance period (“Tranche Year”). The PSUs within each Tranche Year are further divided between two performance targets; the Adjusted EBITDA performance target and free cash flow performance target. The 2023 PSU awards will vest based on achieving 80% to 120% of the performance targets, with the corresponding vested unit amount ranging from 50% to 200% . If the performance targets are met at 100% , the 2023 PSU awards will vest at 287,664 units in the aggregate. No PSUs will vest for each Tranche Year if the Company does not achieve 80% of the Tranche Year’s Adjusted EBITDA and free cash flow targets. The Compensation Committee establishes the annual performance targets at the beginning of each year. Therefore, the grant date (and fair value measurement date) for each Tranche Year is the date at the beginning of each year when a mutual understanding of the key terms and conditions are reached per ASC 718, Compensation – Stock compensation. The 2023 PSU award grant date fair value for the 2023 Tranche Year award of 95,883 units was $3.9 million, the 2022 PSU award grant date fair value for the 2023 Tranche Year award of 46,192 units was $1.9 million, and the 2021 PSU award grant date fair value for the 2023 Tranche Year Award of 160,280 units was $6.8 million, measured using performance targets at 100%. The following table represents the equity classified nonvested RSU and PSU activity for the nine months ended September 30, 2023: Weighted Average Common Stock Grant Date RSUs and PSUs (3) Fair Value Nonvested at January 1, 2023 626,195 $ 59.14 Granted 616,186 39.99 Granted - Special Award 477,918 42.25 Vested (222,920) 57.43 Vested - Special Award (257,945) 42.18 Forfeited (26,036) 44.44 Cancelled (150,755) 60.14 Cancelled - Special Award (219,973) 42.34 Nonvested at September 30, 2023 842,670 $ 45.87 Tranche Years 2024 and 2025 awarded under the 2023 PSU award and Tranche Year 2024 awarded under the 2022 PSU award with grant date fair values to be determined in years 2024 and 2025, respectively 228,199 Total Nonvested at September 30, 2023 1,070,869 (1) The number of PSU shares granted under the Tranche Year 2023 assumes the Company will attain a performance target at 100% for the Adjusted EBITDA target and 100% for the free cash flow target. (2) Represents vested RSUs and PSUs surrendered in lieu of taxes and cancelled awards returned to the 2013 Equity Incentive Plan. As a result, the Company paid taxes for restricted unit withholdings of approximately $14.2 million during the nine months ended September 30, 2023. (3) Includes AMC Preferred Equity Unit RSUs and PSUs that were converted to Common Stock RSUs and PSUs as a result of the Charter Amendments. |
STOCKHOLDERS' EQUITY | Condensed Consolidated Statements of Stockholders’ Deficit For the Nine Months Ended September 30, 2023 Preferred Stock Series A Convertible Accumulated Class A Voting Participating Depositary Shares of Additional Other Total Common Stock Preferred Stock AMC Preferred Paid-in Comprehensive Accumulated Stockholders’ (In millions, except share and per share data) Shares Amount Shares Equity Units Amount Capital Loss Deficit Equity (Deficit) Balances December 31, 2022 51,683,892 $ 0.5 7,245,872 72,458,706 $ 0.1 $ 5,049.8 $ (77.3) $ (7,597.6) $ (2,624.5) Net loss — — — — — — — (235.5) (235.5) Other comprehensive loss — — — — — — (7.3) — (7.3) Share issuance — — 492,880 4,928,800 — 70.5 — — 70.5 Antara Forward Purchase Agreement (2) — — 1,976,213 19,762,130 — 193.7 — — 193.7 Taxes paid for restricted unit withholdings — — — — — (13.1) — — (13.1) Stock-based compensation (1) 235,346 — 26,944 269,444 — 25.9 — — 25.9 Balances March 31, 2023 51,919,238 $ 0.5 9,741,909 97,419,080 $ 0.1 $ 5,326.8 $ (84.6) $ (7,833.1) $ (2,590.3) Net earnings — — — — — — — 8.6 8.6 Other comprehensive loss — — — — — — (40.0) — (40.0) Share issuance — — 212,156 2,121,562 — 32.7 — — 32.7 Taxes paid for restricted unit withholdings — — — — — (1.1) — — (1.1) Stock-based compensation — — — — — 7.5 — — 7.5 Balances June 30, 2023 51,919,238 $ 0.5 9,954,065 99,540,642 $ 0.1 $ 5,365.9 $ (124.6) $ (7,824.5) $ (2,582.6) Net loss — — — — — — — 12.3 12.3 Other comprehensive income — — — — — — 9.2 — 9.2 AMC Preferred Equity Unit conversion 99,540,642 1.0 (9,954,065) (99,540,642) (0.1) (0.9) — — — Settlement payment 6,897,018 0.1 — — — 99.2 — — 99.3 Share issuance 40,000,000 0.4 — — — 316.1 — — 316.5 Stock-based compensation — — — — — 7.3 — — 7.3 Balances September 30, 2023 198,356,898 $ 2.0 — — $ — $ 5,787.6 $ (115.4) $ (7,812.2) $ (2,138.0) (1) Includes 8,555 Common Stock shares and 15,370 AMC Preferred Equity Units awarded to the Board of Directors, 226,791 vested Common Stock RSUs and PSUs, and 254,074 AMC Preferred Equity Units RSUs and PSUs. (2) Includes $75.1 million of cash proceeds and $118.6 million carrying value of the debt exchanged for AMC Preferred Equity Units. Condensed Consolidated Statements of Stockholders’ Deficit For the Nine Months Ended September 30, 2022 Preferred Stock Series A Convertible Accumulated Class A Participating Depositary Shares of Additional Other Total AMC Common Stock Preferred Stock AMC Preferred Paid-in Comprehensive Accumulated Stockholders’ (In millions, except share and per share data) Shares Amount Shares Equity Units Amount Capital Income (Loss) Deficit Equity (Deficit) Balances December 31, 2021 51,397,910 $ 0.5 5,139,791 51,397,910 $ 0.1 $ 4,862.0 $ (28.1) $ (6,624.0) $ (1,789.5) Net loss — — — — — — — (337.4) (337.4) Other comprehensive loss — — — — — — (5.8) — (5.8) Taxes paid for restricted unit withholdings — — — — — (52.2) — — (52.2) Stock-based compensation (1) 284,150 0.1 28,415 284,150 — 6.5 — — 6.6 Balances March 31, 2022 51,682,060 $ 0.6 5,168,206 51,682,060 $ 0.1 $ 4,816.3 $ (33.9) $ (6,961.4) $ (2,178.3) Net loss — — — — — — — (121.6) (121.6) Other comprehensive income — — — — — — (46.3) — (46.3) Stock-based compensation — — — — — 19.4 — — 19.4 Balances June 30, 2022 51,682,060 $ 0.6 5,168,206 51,682,060 $ 0.1 $ 4,835.7 $ (80.2) $ (7,083.0) $ (2,326.8) Net loss — — — — — — — (226.9) (226.9) Other comprehensive loss — — — — — — (26.0) — (26.0) Share issuance — — 27,000 270,000 — 4.3 — — 4.3 Stock-based compensation — — — — — (3.6) — — (3.6) Balances September 30, 2022 51,682,060 $ 0.6 5,195,206 51,952,060 $ 0.1 $ 4,836.4 $ (106.2) $ (7,309.9) $ (2,579.0) (1) Includes 4,165 Common Stock shares and 4,165 AMC Preferred Equity Units awarded to Board of Directors, 279,985 vested Common Stock RSUs and PSUs, and 279,985 vested AMC Preferred Equity Units RSUs and PSUs. |
INCOME TAXES
INCOME TAXES | 9 Months Ended |
Sep. 30, 2023 | |
INCOME TAXES | |
INCOME TAXES | NOTE 8—INCOME TAXES The Company’s worldwide effective income tax rate is based on actual income (loss), statutory rates, valuation allowances against deferred tax assets and tax planning opportunities available in the various jurisdictions in which it operates. The Company is using a discrete income tax calculation for the three and nine months ended September 30, 2023 due to the lingering effects of the COVID-19 pandemic and ongoing labor stoppages on the industry. Historically, for interim financial reporting, the Company estimated the worldwide annual income tax rate based on projected taxable income (loss) for the full year and recorded a quarterly income tax provision or benefit in accordance with the anticipated annual rate, adjusted for discrete items, if any. The Company will return to the historic approach of computing quarterly tax expense based on an annual effective rate in the future interim period when more reliable estimates of annual income become available. The Company recognizes income tax-related interest expense and penalties as income tax expense and general and administrative expense, respectively. The Company evaluates its deferred tax assets each period to determine if a valuation allowance is required based on whether it is “more likely than not” that some portion of the deferred tax assets would not be realized. The ultimate realization of these deferred tax assets is dependent upon the generation of sufficient taxable income during future periods on a federal, state, and foreign jurisdiction basis. The Company conducts its evaluation by considering all available positive and negative evidence, including historical operating results, forecasts of future profitability, the duration of statutory carryforward periods, and the outlooks for the U.S. motion picture and broader economy, among others. A valuation allowance is recorded against the Company’s U.S. deferred tax assets and most of the Company’s international deferred tax assets as the Company has determined the realization of these assets does not meet the more likely than not criteria. The effective tax rate for the nine months ended September 30, 2023 reflects the impact of these valuation allowances against U.S. and international deferred tax assets generated during the period. The actual effective rate for the nine months ended September 30, 2023 was (2.2)%. The Company’s consolidated tax rate for the nine months ended September 30, 2023 differs from the U.S. statutory tax rate primarily due to the valuation allowances in U.S. and foreign jurisdictions, foreign tax rate differences, federal and state tax credits, permanent differences and other discrete items. At September 30, 2023 and December 31, 2022, the Company has recorded net deferred tax liabilities of $32.8 million and $32.1 million, respectively. Utilization of the Company’s net operating loss carryforwards, disallowed business interest carryforwards and other tax attributes became subject to the Section 382 ownership change limitation due to changes in the Company’s stock ownership on January 27, 2021. The Company does not believe, however, that tax attributes generated prior to this event are significantly impacted by Section 382. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 9 Months Ended |
Sep. 30, 2023 | |
FAIR VALUE MEASUREMENTS | |
FAIR VALUE MEASUREMENTS | NOTE 9—FAIR VALUE MEASUREMENTS Fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts business. The inputs used to develop these fair value measurements are established in a hierarchy, which ranks the quality and reliability of the information used to determine the fair values. The fair value classification is based on levels of inputs. Assets and liabilities that are carried at fair value are classified and disclosed in one of the following categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. Recurring Fair Value Measurements. Fair Value Measurements at September 30, 2023 Using Significant Total Carrying Quoted prices in Significant other unobservable Value at active market observable inputs inputs (In millions) September 30, 2023 (Level 1) (Level 2) (Level 3) Other long-term assets: Investment in Hycroft warrants $ 3.8 $ — $ — $ 3.8 Marketable equity securities: Investment in Hycroft 7.0 7.0 — — Total assets at fair value $ 10.8 $ 7.0 $ — $ 3.8 Valuation Techniques. — Other Fair Value Measurement Disclosures. Fair Value Measurements at September 30, 2023 Using Significant other Significant Total Carrying Quoted prices in observable unobservable Value at active market inputs inputs (In millions) September 30, 2023 (Level 1) (Level 2) (Level 3) Current maturities of corporate borrowings $ 20.0 $ — $ 16.2 $ — Corporate borrowings 4,750.4 — 3,542.5 — Valuation Technique. — The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments. |
OPERATING SEGMENTS
OPERATING SEGMENTS | 9 Months Ended |
Sep. 30, 2023 | |
OPERATING SEGMENTS. | |
OPERATING SEGMENTS | NOTE 10—OPERATING SEGMENTS The Company reports information about operating segments in accordance with ASC 280-10, Segment Reporting, which requires financial information to be reported based on the way management organizes segments within a company for making operating decisions and evaluating performance. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. The International markets reportable segment has operations in or partial interest in theatres in the United Kingdom, Germany, Spain, Italy, Ireland, Portugal, Sweden, Finland, Norway, and Denmark. On December 30, 2022, the Company entered into an agreement to sell its 10.0% investment Saudi Cinema Company, LLC for SAR 112.5 million ($30.0 million), subject to certain closing conditions. On January 24, 2023, the Saudi Ministry of Commerce recorded the sale of equity and the Company received the proceeds on January 25, 2023. See Note 5—Investments for further information. Each segment’s revenue is derived from admissions, food and beverage sales and other ancillary revenues, primarily screen advertising, AMC Stubs® membership fees and other loyalty programs, ticket sales, gift card income and exchange ticket income. The measure of segment profit and loss the Company uses to evaluate performance and allocate its resources is Adjusted EBITDA, as defined in the reconciliation table below. The Company does not report asset information by segment because that information is not used to evaluate the performance of or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment: Three Months Ended Nine Months Ended Revenues (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 1,063.9 $ 753.3 $ 2,855.8 $ 2,224.3 International markets 342.0 215.1 852.4 696.2 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 Three Months Ended Nine Months Ended Adjusted EBITDA (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 150.6 $ 1.2 $ 336.3 $ 52.2 International markets 43.1 (14.1) 47.0 (20.1) Total Adjusted EBITDA $ 193.7 $ (12.9) $ 383.3 $ 32.1 (1) The Company presents Adjusted EBITDA as a supplemental measure of its performance. The Company defines Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that the Company does not consider indicative of the Company’s ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in International markets and any cash distributions of earnings from its other equity method investees. The measure of segment profit and loss the Company uses to evaluate performance and allocate its resources is Adjusted EBITDA, which is broadly consistent with how Adjusted EBITDA is defined in the Company’s debt indentures. Three Months Ended Nine Months Ended Capital Expenditures (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 40.8 $ 40.1 $ 112.2 $ 91.5 International markets 16.7 14.4 41.3 38.2 Total capital expenditures $ 57.5 $ 54.5 $ 153.5 $ 129.7 As of As of Long-term assets, net (In millions) September 30, 2023 December 31, 2022 U.S. markets $ 5,854.1 $ 6,135.9 International markets 1,958.9 2,097.6 Total long-term assets $ 7,813.0 $ 8,233.5 (1) Long-term assets are comprised of property, net, operating lease right-of-use assets, intangible assets, goodwill, deferred tax assets, net and other long-term assets. The following table sets forth a reconciliation of net loss to Adjusted EBITDA: Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Net earnings (loss) $ 12.3 $ (226.9) $ (214.6) $ (685.9) Plus: Income tax provision 2.3 1.8 4.6 2.5 Interest expense 103.7 95.7 307.4 278.4 Depreciation and amortization 88.7 96.9 279.1 293.0 Certain operating expense 3.8 4.3 4.0 10.5 Equity in (earnings) loss of non-consolidated entities (3.1) (2.8) (5.3) 3.3 Cash distributions from non-consolidated entities 2.2 3.4 3.9 5.0 Attributable EBITDA 1.4 0.1 1.6 0.1 Investment expense (income) (3.0) 18.3 (11.4) 12.2 Other expense (income) (14.1) 6.2 (1.4) 110.9 Other non-cash rent benefit (8.4) (6.6) (27.0) (20.6) General and administrative — unallocated: Merger, acquisition and other costs 0.7 0.3 1.5 0.4 Stock-based compensation expense 7.2 (3.6) 40.9 22.3 Adjusted EBITDA $ 193.7 $ (12.9) $ 383.3 $ 32.1 (1) Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens, including the related accretion of interest, disposition of assets and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature or are non-operating in nature. (2) Includes U.S. non-theatre distributions from equity method investments and International non- theatre distributions from equity method investments to the extent received. The Company believes including cash distributions is an appropriate reflection of the contribution of these investments to the Company’s operations. (3) Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain International markets. See below for a reconciliation of the Company’s equity in loss of non-consolidated entities to attributable EBITDA. Because these equity investments in theatre operators are in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. The Company also provides services to these theatre operators including information technology systems, certain on-screen advertising services and the Company’s gift card and package ticket program. Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Equity in (earnings) loss of non-consolidated entities $ (3.1) $ (2.8) $ (5.3) $ 3.3 Less: Equity in (earnings) of non-consolidated entities excluding International theatre joint ventures (2.1) (3.5) (4.7) (3.1) Equity in earnings (loss) of International theatre joint ventures 1.0 (0.7) 0.6 (6.4) Income tax provision (benefit) 0.1 0.1 (0.1) 0.1 Investment expense (income) (0.2) — (0.1) 0.2 Interest expense 0.1 — 0.2 — Impairment of long-lived assets — — — 4.2 Depreciation and amortization 0.4 0.7 1.0 2.0 Attributable EBITDA $ 1.4 $ 0.1 $ 1.6 $ 0.1 (4) Investment expense (income) during the three months ended September 30, 2023 primarily includes appreciation in estimated fair value of the Company’s investment in common shares of Hycroft of $(0.1) million, deterioration in estimated fair value of the Company’s investment in warrants to purchase common shares of Hycroft of $0.8 million and interest income of $(3.7) million. During the three months ended September 30, 2022, investment expense (income) included deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $11.8 million, deterioration in estimated fair value of the Company's investment in warrants to purchase common shares of Hycroft of $7.7 million, and $1.6 million decline in estimated fair value of the Company’s investment in NCM Common Units, partially offset by interest income of $(2.8) million. Investment expense (income) during the nine months ended September 30, 2023 includes deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $5.4 million, deterioration in estimated fair value of the Company’s investment in warrants to purchase common shares of Hycroft of $5.4 million, $1.8 million of expense for NCM Common Units, $(15.5) million gain on the sale of the Company’s investment in Saudi Cinema Company, LLC and interest income of $(8.5) million. During the nine months ended September 30, 2022, investment expense (income) included deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $10.8 million, $11.1 million decline in estimated fair value of the Company’s investment in NCM Common Units, partially offset by appreciation in estimated fair value of the Company’s investment to purchase common shares of Hycroft of $(7.4) million and interest income of $(3.3) million. (5) Other expense (income) during the three months ended September 30, 2023 includes a non-cash litigation adjustment of $(16.1) million, income related to foreign currency transaction losses of $12.8 million and gains on debt extinguishment of $(10.8) million. During the three months ended September 30, 2022, other expense (income) included foreign currency transaction losses of $6.3 million. Other expense (income) during the nine months ended September 30, 2023 includes a non-cash litigation charge of $99.3 million, partially offset by gains on debt extinguishment of $(97.5) million and foreign currency transaction gains of $(3.2) million. During the nine months ended September 30, 2022, other expense (income) included loss on debt extinguishment of $96.4 million and foreign currency transaction losses of $14.7 million. (6) Reflects amortization expense for certain intangible assets reclassified from depreciation and amortization to rent expense due to the adoption of ASC 842, Leases and deferred rent benefit related to the impairment of right-of-use operating lease assets. (7) Merger, acquisition and other costs are excluded as they are non-operating in nature. (8) Non-cash or non-recurring expense included in general and administrative: other. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2023 | |
COMMITMENTS AND CONTINGENCIES | |
COMMITMENTS AND CONTINGENCIES | NOTE 11—COMMITMENTS AND CONTINGENCIES The Company, in the normal course of business, is a party to various ordinary course claims from vendors (including food and beverage suppliers and film distributors), landlords, competitors, and other legal proceedings. If management believes that a loss arising from these actions is probable and can reasonably be estimated, the Company records the amount of the loss or the minimum estimated liability when the loss is estimated using a range and no point is more probable than another. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of such matters discussed below, individually and in the aggregate, will not have a material adverse effect on the Company’s financial position or overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur. An unfavorable outcome might include monetary damages. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods. On January 12, 2018 and January 19, 2018, two putative federal securities class actions, captioned Hawaii Structural Ironworkers Pension Trust Fund v. AMC Entertainment Holdings, Inc., et al., Case No. 1:18-cv-00299-AJN (the “Hawaii Action”), and Nichols v. AMC Entertainment Holdings, Inc., et al., Case No. 1:18-cv-00510-AJN (the “Nichols Action,” and together with the Hawaii Action, the “Actions”), respectively, were filed against the Company in the U.S. District Court for the Southern District of New York. The Actions, which named certain of the Company’s officers and directors and, in the case of the Hawaii Action, the underwriters of the Company’s February 8, 2017 secondary public offering, as defendants, asserted claims under Sections 11, 12(a)(2) and 15 of the Securities Act and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) with respect to alleged material misstatements and omissions in the registration statement for the secondary public offering and in certain other public disclosures. On May 30, 2018, the court consolidated the Actions. On January 22, 2019, defendants moved to dismiss the Second Amended Class Action Complaint. On September 23, 2019, the court granted the motion to dismiss in part and denied it in part. On March 2, 2020, plaintiffs moved to certify the purported class. On March 30, 2021, the court granted the motion to certify the class. On September 2, 2021, the parties reached an agreement in principle to resolve the Actions for $18.0 million. The Company agreed to the settlement and the payment of the settlement amount to eliminate the distraction, burden, expense, and uncertainty of further litigation. The Company and the other defendants continue to expressly deny any liability or wrongdoing with respect to the matters alleged in the Actions. On November 1, 2021, the parties to the Actions signed a stipulation of settlement, which memorialized the terms of the agreement in principle, and which the plaintiffs filed with the court. Also on November 1, 2021, plaintiffs filed a motion to preliminarily approve the settlement. On November 8, 2021, the court preliminarily approved the settlement, approved the form of notice to be disseminated to class members, and scheduled a final fairness hearing on the settlement for February 10, 2022. On February 14, 2022, the court issued a final judgment approving the settlement and dismissing the action. On May 21, 2018, a stockholder derivative complaint, captioned Gantulga v. Aron, et al. Gantulga v. Aron, et al. On October 2, 2019, a stockholder derivative complaint, captioned Kenna v. Aron On March 20, 2020, a stockholder derivative complaint, captioned Manuel v. Aron, et al On April 7, 2020, a stockholder derivative complaint, captioned Dinkevich v. Aron, et al On September 23, 2021, a stockholder derivative complaint, captioned Lyon v. Aron, et al. On June 14, 2023, the parties to the Gantulga, Kenna, Manuel, Dinkevich, and Lyon Actions signed a stipulation of settlement, which subject to the approval of the court, will resolve those actions. As consideration for the proposed settlement, the Company agreed to certain corporate governance reforms. The Company also agreed to the payment of a $1.0 million fee and expense award to the plaintiffs’ attorneys to be paid by the Company’s director’s and officer’s insurance carriers. Defendants agreed to the settlement solely to eliminate the burden, expense, and uncertainties inherent in further litigation. Defendants have denied, and continue to deny, all allegations of wrongdoing, fault, liability, or damages with respect to the matters alleged in the Gantulga, Kenna, Manuel, Dinkevich, and Lyon Actions. On June 23, 2023, plaintiffs filed a motion to preliminarily approve the settlement. On October 6, 2023, the Court preliminarily approved the proposed settlement as being fair, reasonable, and adequate, and scheduled a telephonic hearing for December 18, 2023 at 11:00 a.m. eastern time, to, among other things, consider whether to approve the proposed settlement. On December 31, 2019, the Company received a stockholder litigation demand, requesting that the Board investigate the allegations in the Actions and pursue claims on the Company’s behalf based on those allegations. On May 5, 2020, the Board determined not to pursue the claims sought in the demand at that time. On July 15, 2020, the Company received a second stockholder litigation demand requesting substantially the same action as the stockholder demand it received on December 31, 2019. On September 23, 2020, the Board determined not to pursue the claims sought in the demand at that time. On April 22, 2019, a putative stockholder class and derivative complaint, captioned Lao v. Dalian Wanda Group Co., Ltd. On December 27, 2022, the Company received a letter from a purported stockholder, demanding to inspect certain of the Company’s books and records pursuant to 8 Del. C On February 6, 2023, the Company received a letter from another purported stockholder, demanding to inspect certain of the Company’s books and records pursuant to 8 Del. C On February 20, 2023, two putative stockholder class actions were filed in the Delaware Court of Chancery, captioned Allegheny County Employees’ Retirement System v. AMC Entertainment Holdings, Inc., et al., Munoz v Adam M. Aron, et al., In re AMC Entertainment Holdings, Inc. Stockholder Litigation Allegheny Del. C Munoz Allegheny Allegheny Del. C or that the APEs be enjoined from voting on the Charter Amendments, and an award of money damages. The Munoz On February 27, 2023, the Delaware Court of Chancery entered a status quo order that (i) allowed the March 14, 2023 vote on the Charter Amendments to proceed, but precluded the Company from implementing the Charter Amendments pending a ruling by the court on the plaintiffs’ then-anticipated preliminary injunction motion, and (ii) scheduled a hearing on the plaintiffs’ then-anticipated preliminary injunction motion for April 27, 2023 (the “Status Quo Order”). On April 2, 2023, the parties entered into a binding settlement term sheet to settle the Shareholder Litigation, which among other things, provided that the parties would jointly request that the Status Quo Order be lifted. Pursuant to the term sheet, the Company agreed to make a non-cash settlement payment to record holders of Common Stock as of the time (the “Settlement Class Time”) at which the Reverse Stock Split would be effective (and after giving effect to the Reverse Stock Split) of one On April 5, 2023, the court denied the motion to lift the Status Quo Order. On April 27, 2023, the parties jointly filed a Stipulation and Agreement of Compromise, Settlement, and Release (the “Settlement Stipulation”) with the court, which fully memorialized the settlement that the parties agreed to in the term sheet. On June 29–30, 2023, the court held a settlement hearing to consider whether to approve the settlement as outlined in the Settlement Stipulation. On July 21, 2023, the court issued an opinion which, citing issues with the scope of the release sought under the proposed settlement, declined to approve the settlement as presented. On July 22, 2023, the parties filed an addendum to the Settlement Stipulation in an effort to address the issues with the scope of the release raised by the court and requested that the court approve the settlement with the revised release set forth in the addendum. On July 24, 2023, the court responded to the parties’ July 22, 2023 filings requesting additional submissions in relation to the proposed settlement. The Company provided the additional requested submissions to the court on July 26, 2023. On August 11, 2023, the court approved the settlement of the Shareholder Litigation and lifted the Status Quo Order. On August 14, 2023, the Company filed the amendment to its Third Amended and Restated Certificate of Incorporation, which was previously approved by the Company’s stockholders at the special meeting held on March 14, 2023 to implement the Charter Amendments effective as of August 24, 2023. The Reverse Stock Split occurred on August 24, 2023, the conversion of APEs into Common Stock occurred on August 25, 2023, and the Settlement Payment was made on August 28, 2023. On September 15, 2023, the Court entered an order dismissing the Shareholder Litigation in its entirety and with prejudice. On October 13, 2023, a purported Company stockholder who objected to the settlement of the Shareholder Litigation filed a notice of appeal to the settlement. In connection with the Settlement Payment, the Company recorded a $110.1 million charge to other expense during the nine months ended September 30, 2023. The charge was based on the estimated fair value of $99.3 million for the Settlement Payment and $10.8 million of legal fees, net of probable insurance recoveries. The Company made the Settlement Payment on August 28, 2023, and recorded the disbursement to stockholders’ equity. The legal fee liabilities are included in accrued expenses and other liabilities or accounts payable within the condensed consolidated balance sheets. On August 14, 2023, a putative class action on behalf of APE holders, captioned Simons v. AMC Entertainment Holdings, Inc. On May 4, 2023, the Company filed a lawsuit in the Superior Court of the State of Delaware against seventeen insurers participating in its directors & officers insurance program, seeking recovery for losses incurred in connection with its defense and settlement of the Shareholder Litigation, including the Settlement Payment. The insurance recovery action is captioned, AMC Entertainment Holdings, Inc. v. XL Specialty Insurance Co., et al On October 6, 2023, an action captioned Matthew, et al. v. Citigroup Global Markets, et al. |
EARNINGS (LOSS) PER SHARE
EARNINGS (LOSS) PER SHARE | 9 Months Ended |
Sep. 30, 2023 | |
EARNINGS (LOSS) PER SHARE | |
EARNINGS (LOSS) PER SHARE | NOTE 12—EARNINGS (LOSS) PER SHARE On August 4, 2022, the Company announced that its Board of Directors declared a special dividend of one AMC Preferred Equity Unit for each share of Common Stock outstanding at the close of business on August 15, 2022, the record date. The dividend was paid at the close of business on August 19, 2022 to investors who held Common Stock as of August 22, 2022, the ex-dividend date. Due to the characteristics of the AMC Preferred Equity Units, the special dividend had the effect of a stock split pursuant to ASC 505-20-25-4. On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one one Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect both the effects of the special dividend as a stock split and the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares. Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted earnings (loss) per share includes the effects of unvested RSUs with a service condition only and unvested contingently issuable PSUs that have service and performance conditions, if dilutive. The following table sets forth the computation of basic and diluted earnings (loss) per common share: Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Numerator: Net earnings (loss) for basic earnings (loss) per share $ 12.3 $ (226.9) $ (214.6) $ (685.9) Net earnings (loss) for diluted earnings (loss) per share $ 12.3 $ (226.9) $ (214.6) $ (685.9) Denominator Weighted average shares for basic earnings (loss) per common share 162,424 103,369 150,465 103,306 Common equivalent shares for RSUs and PSUs 183 — — — Weighted average shares for diluted earnings (loss) per common share 162,607 103,369 150,465 103,306 Basic earnings (loss) per common share $ 0.08 $ (2.20) $ (1.43) $ (6.64) Diluted earnings (loss) per common share $ 0.08 $ (2.20) $ (1.43) $ (6.64) Vested RSUs and PSUs have dividend rights identical to the Company’s Common Stock and are treated as outstanding shares for purposes of computing basic and diluted earnings per share. Unvested RSUs of 467,353 and 548,419 for the three and nine months ended September 30, 2023, respectively were not included in the computation of diluted earnings (loss) per share because they would be anti-dilutive. Unvested RSUs of 542,815 for the three and nine months ended September 30, 2022 were not included in the computation of diluted loss per share because they would be anti-dilutive. Unvested PSUs are subject to performance conditions and are included in diluted earnings per share, if dilutive, based on the number of shares, if any, that would be issuable under the terms of the Company’s 2013 Equity Incentive Plan if the end of the reporting period were the end of the contingency period. Unvested PSUs of 192,052 and 294,251 for the three and nine months ended September 30, 2023, respectively were not included in the computation of diluted earnings (loss) per share because they would not be issuable if the end of the reporting period were the end of the contingency period or they would be anti-dilutive. Unvested PSUs of 283,809 at certain performance targets for the three and nine months ended September 30, 2022, were not included in the computation of diluted loss per share because they would not be issuable if the end of the reporting period were the end of the contingency period or they would be anti-dilutive. |
BASIS OF PRESENTATION (Policies
BASIS OF PRESENTATION (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
BASIS OF PRESENTATION | |
Stock Split and Reverse Stock Split | Stock Split and Reverse Stock Split On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one one Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect both the effects of the special dividend as a stock split and the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares. |
Liquidity | Liquidity. The Company’s cash burn rates are not sustainable long-term. In order to achieve sustainable net positive operating cash flows and long-term profitability, the Company believes that operating revenues will need to increase to levels in line with pre-COVID operating revenues. North American box office grosses were down approximately 16% for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2019. Until such time as the Company is able to achieve positive operating cash flow, it is difficult to estimate the Company’s liquidity requirements, future cash burn rates, future operating revenues, and attendance levels. Depending on the Company’s assumptions regarding the timing and ability to achieve increased levels of operating revenue, the estimates of amounts of required liquidity vary significantly. There can be no assurance that the operating revenues, attendance levels, and other assumptions used to estimate the Company’s liquidity requirements and future cash burn rates will be correct, and the ability to be predictive is uncertain due to limited ability to predict studio film release dates, the overall production and theatrical release levels, and success of individual titles. Additionally, the effects of labor stoppages, including but not limited to the Writers Guild of America strike that began on May 2, 2023 and ended on September 27, 2023, and the Screen Actors Guild – American Federation of Television and Radio Artists strike that began on July 14, 2023, cannot be reasonably estimated and may have a negative impact on the future film slate for exhibition, the Company’s future liquidity and cash burn rates. Further, there can be no assurances that the Company will be successful in generating the additional liquidity necessary to meet the Company’s obligations beyond twelve months from the issuance of these financial statements on terms acceptable to the Company or at all. The Company may, at any time and from time to time, seek to retire or purchase its outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as it may determine, and will depend on prevailing market conditions, its liquidity requirements, contractual restrictions and other factors. The amounts involved may be material and to the extent equity is used, dilutive. On December 22, 2022, the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Antara Capital LP (“Antara”) pursuant to which the Company agreed to (i) sell to Antara 10,659,511 AMC Preferred Equity Units for an aggregate purchase price of $75.1 million and (ii) simultaneously purchase from Antara $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026 in exchange for 9,102,619 AMC Preferred Equity Units. On February 7, 2023, the Company issued 19,762,130 AMC Preferred Equity Units to Antara in exchange for $75.1 million in cash and $100.0 million aggregate principal amount of the Company’s 10%/12% Cash/PIK Toggle Second Lien Notes due 2026. The Company recorded $193.7 million to stockholders’ deficit as a result of the transaction. The Company paid $1.4 million of accrued interest in cash upon exchange of the notes. See Note 7—Stockholders’ Equity for more information. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $114.5 million and paid fees to a sales agent and incurred other third-party issuance costs of approximately $2.9 million and $8.7 million, respectively, through its at-the-market offering of approximately 7.1 million shares of its AMC Preferred Equity Units. The Company paid $11.5 million of other third-party issuance costs during the nine months ended September 30, 2023. During the nine months ended September 30, 2023, the Company raised gross proceeds of approximately $325.5 million and paid fees to a sales agent and incurred other third-party issuance costs of approximately $8.2 million and $0.5 million, respectively, through its at-the-market offering of 40.0 million shares of its Common Stock. The Company paid $0.1 million of other third-party issuance costs during the nine months ended September 30, 2023. See Note 7—Stockholders’ Equity for further information regarding the at-the-market offerings. The below table summarizes the cash debt repurchase transactions during the nine months ended September 30, 2023, including related party transactions with Antara, which was a related party from February 7, 2023 to August 25, 2023. See Note 6—Corporate Borrowings and Finance Lease Liabilities for more information. Aggregate Principal Reacquisition Gain on Accrued Interest (In millions) Repurchased Cost Extinguishment Paid Related party transactions: Second Lien Notes due 2026 $ 75.9 $ 48.5 $ 40.9 $ 1.1 5.875% Senior Subordinated Notes due 2026 4.1 1.7 2.3 0.1 Total related party transactions 80.0 50.2 43.2 1.2 Non-related party transactions: Second Lien Notes due 2026 89.7 51.3 54.3 2.2 Total non-related party transactions 89.7 51.3 54.3 2.2 Total debt repurchases $ 169.7 $ 101.5 $ 97.5 $ 3.4 |
Use of Estimates | Use of Estimates. |
Principles of Consolidation | Principles of Consolidation. |
Cash and Cash Equivalents | Cash and Cash Equivalents. |
Restricted Cash | Restricted Cash. Period Ended (In millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 729.7 $ 631.5 Restricted cash 22.4 22.9 Total cash and cash equivalents and restricted cash in the statement of cash flows $ 752.1 $ 654.4 |
Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss. Foreign (In millions) Currency Pension Benefits Total Balance December 31, 2022 $ (78.8) $ 1.5 $ (77.3) Other comprehensive loss (38.1) — (38.1) Balance September 30, 2023 $ (116.9) $ 1.5 $ (115.4) |
Accumulated Depreciation and Amortization | Accumulated Depreciation and Amortization. |
Other Expense (Income) | Other Expense (Income). Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Decreases related to contingent lease guarantees $ — $ (0.1) $ — $ (0.2) Governmental assistance due to COVID-19 - International markets — (5.4) — (16.2) Governmental assistance due to COVID-19 - U.S. markets — (1.6) — (2.7) Foreign currency transaction (gains) losses 12.8 6.3 (3.2) 14.7 Non-operating components of net periodic benefit cost (income) 0.5 (0.2) 1.2 (0.4) Gain on extinguishment - Senior Subordinated Notes due 2026 — — (2.3) — Loss on extinguishment - First Lien Notes due 2025 — — — 47.7 Loss on extinguishment - First Lien Notes due 2026 — — — 54.4 Loss on extinguishment - First Lien Toggle Notes due 2026 — — — 32.9 Gain on extinguishment - Second Lien Notes due 2026 (10.8) — (95.2) (38.6) Derivative stockholder settlement — — (14.0) — Shareholder litigation (15.3) — 110.1 — Business interruption insurance recoveries — — (1.3) — Total other expense (income) $ (12.8) $ (1.0) $ (4.7) $ 91.6 |
Accounting Pronouncements Recently Adopted | Accounting Pronouncements Recently Adopted Reference Rate Reform. |
BASIS OF PRESENTATION (Tables)
BASIS OF PRESENTATION (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
BASIS OF PRESENTATION | |
Schedule of debt repurchases transactions | The below table summarizes the cash debt repurchase transactions during the nine months ended September 30, 2023, including the related party transactions with Antara, which was a related party from February 7, 2023 to August 25, 2023: Aggregate Principal Reacquisition Gain on Accrued Interest (In millions) Repurchased Cost Extinguishment Paid Related party transactions: Second Lien Notes due 2026 $ 75.9 $ 48.5 $ 40.9 $ 1.1 5.875% Senior Subordinated Notes due 2026 4.1 1.7 2.3 0.1 Total related party transactions 80.0 50.2 43.2 1.2 Non-related party transactions: Second Lien Notes due 2026 89.7 51.3 54.3 2.2 Total non-related party transactions 89.7 51.3 54.3 2.2 Total debt repurchases $ 169.7 $ 101.5 $ 97.5 $ 3.4 |
Schedule of consolidated statement of cash flows | Period Ended (In millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 729.7 $ 631.5 Restricted cash 22.4 22.9 Total cash and cash equivalents and restricted cash in the statement of cash flows $ 752.1 $ 654.4 |
Schedule of change in accumulated other comprehensive income (loss) | Foreign (In millions) Currency Pension Benefits Total Balance December 31, 2022 $ (78.8) $ 1.5 $ (77.3) Other comprehensive loss (38.1) — (38.1) Balance September 30, 2023 $ (116.9) $ 1.5 $ (115.4) |
Schedule components of other expense (income) | Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Decreases related to contingent lease guarantees $ — $ (0.1) $ — $ (0.2) Governmental assistance due to COVID-19 - International markets — (5.4) — (16.2) Governmental assistance due to COVID-19 - U.S. markets — (1.6) — (2.7) Foreign currency transaction (gains) losses 12.8 6.3 (3.2) 14.7 Non-operating components of net periodic benefit cost (income) 0.5 (0.2) 1.2 (0.4) Gain on extinguishment - Senior Subordinated Notes due 2026 — — (2.3) — Loss on extinguishment - First Lien Notes due 2025 — — — 47.7 Loss on extinguishment - First Lien Notes due 2026 — — — 54.4 Loss on extinguishment - First Lien Toggle Notes due 2026 — — — 32.9 Gain on extinguishment - Second Lien Notes due 2026 (10.8) — (95.2) (38.6) Derivative stockholder settlement — — (14.0) — Shareholder litigation (15.3) — 110.1 — Business interruption insurance recoveries — — (1.3) — Total other expense (income) $ (12.8) $ (1.0) $ (4.7) $ 91.6 |
LEASES (Tables)
LEASES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
LEASES | |
Schedule of deferred payment amounts related to rent obligations for which payments have been deferred | As of As of December 31, Decrease September 30, (In millions) 2022 in deferred amounts 2023 Fixed operating lease deferred amounts $ 150.3 $ (80.0) $ 70.3 Finance lease deferred amounts 0.9 (0.7) 0.2 Variable lease deferred amounts 6.0 (2.3) 3.7 Total deferred lease amounts $ 157.2 $ (83.0) $ 74.2 (1) During the nine months ended September 30, 2023, the decrease in fixed operating lease deferred amounts includes $13.3 million of rent payments that are included in change in accounts payable and $66.7 million included in deferred rent and other non-cash rent in the condensed consolidated statement of cash flows. |
Schedule of components of lease costs | Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (In millions) Consolidated Statements of Operations 2023 2022 2023 2022 Operating lease cost Theatre properties Rent $ 201.3 $ 202.0 $ 587.5 $ 608.9 Theatre properties Operating expense 0.6 1.5 1.2 4.1 Equipment Operating expense 4.8 2.7 11.8 7.4 Office and other General and administrative: other 1.3 1.3 4.0 4.0 Finance lease cost Amortization of finance lease assets Depreciation and amortization 0.5 0.6 1.5 2.0 Interest expense on lease liabilities Finance lease obligations 0.9 0.9 2.8 3.1 Variable lease cost Theatre properties Rent 23.0 21.2 63.3 59.9 Equipment Operating expense 17.9 13.4 51.6 44.8 Total lease cost $ 250.3 $ 243.6 $ 723.7 $ 734.2 |
Schedule of cash flow and supplemental information | Nine Months Ended September 30, September 30, (In millions) 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in finance leases $ (2.3) $ (2.9) Operating cash flows used in operating leases (742.5) (775.9) Financing cash flows used in finance leases (4.6) (7.9) Landlord contributions: Operating cashflows provided by operating leases 16.0 16.2 Supplemental disclosure of noncash leasing activities: Right-of-use assets obtained in exchange for new operating lease liabilities 111.4 220.8 (1) Includes lease extensions and option exercises. |
Schedule of weighted average remaining lease term and discount rate | As of September 30, 2023 Weighted Average Weighted Average Remaining Discount Lease Term and Discount Rate Lease Term (years) Rate Operating leases 8.9 10.4% Finance leases 13.4 6.4% |
Schedule of minimum annual payments required under existing leases | Operating Lease Finance Lease (In millions) Payments (2) Payments (2) Three months ending December 31, 2023 $ 241.7 2.2 2024 891.2 8.1 2025 847.1 7.4 2026 781.7 7.3 2027 717.1 7.3 2028 633.5 6.9 Thereafter 2,736.9 44.4 Total lease payments 6,849.2 83.6 Less imputed interest (2,357.2) (29.1) Total operating and finance lease liabilities, respectively $ 4,492.0 $ 54.5 (1) The minimum annual payments table above does not include contractual cash rent amounts that were due and not paid, which are recorded in accounts payable as shown below, including estimated repayment dates: Accounts Payable (In millions) Lease Payments Three months ended December 31, 2023 $ 5.7 2024 1.0 2025 0.8 2026 0.7 2027 0.3 2028 0.1 Thereafter 0.1 Total deferred lease amounts recorded in accounts payable $ 8.7 (2) The minimum annual payments table above includes deferred undiscounted cash rent amounts that were due and not paid related to operating and finance leases, as shown below: Operating Lease Finance Lease (In millions) Payments Payments Three months ended December 31, 2023 $ 15.6 $ 0.1 2024 15.6 — 2025 5.7 — 2026 4.2 — 2027 3.4 — 2028 3.2 — Thereafter 17.7 — Total deferred lease amounts $ 65.4 $ 0.1 |
Schedule of contractual rent amounts due and not paid included in accounts payable | Accounts Payable (In millions) Lease Payments Three months ended December 31, 2023 $ 5.7 2024 1.0 2025 0.8 2026 0.7 2027 0.3 2028 0.1 Thereafter 0.1 Total deferred lease amounts recorded in accounts payable $ 8.7 |
Schedule of deferred lease payments included in the minimum annual payments also included in a separate commitment | Operating Lease Finance Lease (In millions) Payments Payments Three months ended December 31, 2023 $ 15.6 $ 0.1 2024 15.6 — 2025 5.7 — 2026 4.2 — 2027 3.4 — 2028 3.2 — Thereafter 17.7 — Total deferred lease amounts $ 65.4 $ 0.1 |
REVENUE RECOGNITION (Tables)
REVENUE RECOGNITION (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Disaggregation of Revenue [Line Items] | |
Schedule of disaggregated revenue | Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Major revenue types Admissions $ 797.7 $ 545.3 $ 2,075.9 $ 1,640.1 Food and beverage 482.7 333.3 1,299.6 982.5 Other theatre: Screen advertising 33.2 29.0 96.4 90.2 Other 92.3 60.8 236.3 207.7 Other theatre 125.5 89.8 332.7 297.9 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Timing of revenue recognition Products and services transferred at a point in time $ 1,299.3 $ 884.5 $ 3,431.5 $ 2,675.3 Products and services transferred over time 106.6 83.9 276.7 245.2 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 (1) Amounts primarily include subscription and advertising revenues. |
Schedule of receivables and deferred revenue income | (In millions) September 30, 2023 December 31, 2022 Current assets Receivables related to contracts with customers $ 54.4 $ 92.3 Miscellaneous receivables 79.8 74.3 Receivables, net $ 134.2 $ 166.6 (In millions) September 30, 2023 December 31, 2022 Current liabilities Deferred revenues related to contracts with customers $ 405.7 $ 398.8 Miscellaneous deferred income 5.3 3.9 Deferred revenues and income $ 411.0 $ 402.7 |
Customers included in deferred revenues and income | |
Disaggregation of Revenue [Line Items] | |
Schedule of changes in contract liabilities | Deferred Revenues Related to Contracts (In millions) with Customers Balance December 31, 2022 $ 398.8 Cash received in advance 248.5 Customer loyalty rewards accumulated, net of expirations: Admission revenues 17.4 Food and beverage 31.6 Other theatre (0.7) Reclassification to revenue as the result of performance obligations satisfied: Admission revenues (197.8) Food and beverage (58.7) Other theatre (33.9) Foreign currency translation adjustment 0.5 Balance September 30, 2023 $ 405.7 (1) Includes movie tickets, food and beverage, gift cards, exchange tickets, and AMC Stubs® loyalty membership fees. (2) Amount of rewards accumulated, net of expirations, that are attributed to AMC Stubs® and other loyalty programs. (3) Amount of rewards redeemed that are attributed to gift cards, exchange tickets, movie tickets, AMC Stubs® loyalty programs and other loyalty programs. (4) Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, AMC Stubs® loyalty membership fees and other loyalty programs. |
Exhibitor services agreement | |
Disaggregation of Revenue [Line Items] | |
Schedule of changes in contract liabilities | Exhibitor Services (In millions) Agreement (1) Balance December 31, 2022 $ 505.8 Reclassification, net of adjustments, for portion of the beginning balance to other theatre revenue, as the result of performance obligations satisfied (13.8) Balance September 30, 2023 $ 492.0 (1) Represents the carrying amount of the National CineMedia, LLC (“NCM”) common units that were previously received under the annual Common Unit Adjustment (“CUA”) and subsequent adjustments related to the NCM Bankruptcy, as discussed in greater detail below. The deferred revenues are being amortized to other theatre revenues over the remainder of the 30-year term of the Exhibitor Service Agreement (“ESA”) ending in February 2037. |
GOODWILL (Tables)
GOODWILL (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
GOODWILL. | |
Summary of the changes in goodwill by reporting unit | U.S. Markets International Markets Consolidated Goodwill (In millions) Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Gross Carrying Amount Accumulated Impairment Losses Net Carrying Amount Balance December 31, 2022 $ 3,072.6 $ (1,276.1) $ 1,796.5 $ 1,521.8 $ (976.3) $ 545.5 $ 4,594.4 $ (2,252.4) $ 2,342.0 Currency translation adjustment — — — (23.6) (7.6) (31.2) (23.6) (7.6) (31.2) Balance September 30, 2023 $ 3,072.6 $ (1,276.1) $ 1,796.5 $ 1,498.2 $ (983.9) $ 514.3 $ 4,570.8 $ (2,260.0) $ 2,310.8 |
CORPORATE BORROWINGS AND FINA_2
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES | |
Summary of the carrying value of corporate borrowings and capital and financing lease obligations | (In millions) September 30, 2023 December 31, 2022 First Lien Secured Debt: Senior Secured Credit Facility-Term Loan due 2026 (8.427% as of September 30, 2023 and 7.274% as of December 31, 2022) $ 1,910.0 $ 1,925.0 12.75% Odeon Senior Secured Notes due 2027 400.0 400.0 7.5% First Lien Notes due 2029 950.0 950.0 Second Lien Secured Debt: 10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 1,124.2 1,389.8 Subordinated Debt: 6.375% Senior Subordinated Notes due 2024 (£4.0 million par value as of September 30, 2023) 4.9 4.8 5.75% Senior Subordinated Notes due 2025 98.3 98.3 5.875% Senior Subordinated Notes due 2026 51.5 55.6 6.125% Senior Subordinated Notes due 2027 125.5 125.5 Total principal amount of corporate borrowings $ 4,664.4 $ 4,949.0 Finance lease liabilities 54.5 58.8 Deferred financing costs (33.0) (37.9) Net premium 139.0 229.7 Total carrying value of corporate borrowings and finance lease liabilities $ 4,824.9 $ 5,199.6 Less: Current maturities of corporate borrowings (20.0) (20.0) Current maturities of finance lease liabilities (6.2) (5.5) Total noncurrent carrying value of corporate borrowings and finance lease liabilities $ 4,798.7 $ 5,174.1 |
Summary of net premium (discount) amounts of corporate borrowings | September 30, December 31, (In millions) 2023 2022 10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 $ 170.4 $ 265.5 Senior Secured Credit Facility-Term Loan due 2026 (3.7) (4.8) 12.75% Odeon Senior Secured Notes due 2027 (27.7) (31.1) 6.375% Senior Subordinated Notes due 2024 — 0.1 Net premium $ 139.0 $ 229.7 |
Schedule of minimum annual payments required under existing capital and financing lease obligations (net present value thereof) and maturities of corporate borrowings | Principal Amount of Corporate (In millions) Borrowings Three months ended December 31, 2023 $ 5.0 2024 24.9 2025 118.3 2026 3,040.7 2027 525.5 2028 — Thereafter 950.0 Total $ 4,664.4 |
Schedule of debt repurchases transactions | The below table summarizes the cash debt repurchase transactions during the nine months ended September 30, 2023, including the related party transactions with Antara, which was a related party from February 7, 2023 to August 25, 2023: Aggregate Principal Reacquisition Gain on Accrued Interest (In millions) Repurchased Cost Extinguishment Paid Related party transactions: Second Lien Notes due 2026 $ 75.9 $ 48.5 $ 40.9 $ 1.1 5.875% Senior Subordinated Notes due 2026 4.1 1.7 2.3 0.1 Total related party transactions 80.0 50.2 43.2 1.2 Non-related party transactions: Second Lien Notes due 2026 89.7 51.3 54.3 2.2 Total non-related party transactions 89.7 51.3 54.3 2.2 Total debt repurchases $ 169.7 $ 101.5 $ 97.5 $ 3.4 |
STOCKHOLDERS' EQUITY (Tables)
STOCKHOLDERS' EQUITY (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
STOCKHOLDERS' EQUITY | |
Summary of stock based compensation | Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (In millions) 2023 2022 2023 2022 Equity classified awards: Special awards expense $ — $ — $ 20.2 $ — Board of director stock award expense — — 0.9 0.8 Restricted stock unit expense 3.7 3.5 10.5 9.8 Performance stock unit expense 3.6 (7.1) 9.0 11.7 Total equity classified awards: 7.3 (3.6) 40.6 22.3 Liability classified awards: Restricted and performance stock unit expense (0.1) — 0.3 — Total liability classified awards: (0.1) — 0.3 — Total stock-based compensation expense $ 7.2 $ (3.6) $ 40.9 $ 22.3 |
Schedule of Nonvested RSU, PSU and SPSU Activity | Weighted Average Common Stock Grant Date RSUs and PSUs (3) Fair Value Nonvested at January 1, 2023 626,195 $ 59.14 Granted 616,186 39.99 Granted - Special Award 477,918 42.25 Vested (222,920) 57.43 Vested - Special Award (257,945) 42.18 Forfeited (26,036) 44.44 Cancelled (150,755) 60.14 Cancelled - Special Award (219,973) 42.34 Nonvested at September 30, 2023 842,670 $ 45.87 Tranche Years 2024 and 2025 awarded under the 2023 PSU award and Tranche Year 2024 awarded under the 2022 PSU award with grant date fair values to be determined in years 2024 and 2025, respectively 228,199 Total Nonvested at September 30, 2023 1,070,869 (1) The number of PSU shares granted under the Tranche Year 2023 assumes the Company will attain a performance target at 100% for the Adjusted EBITDA target and 100% for the free cash flow target. (2) Represents vested RSUs and PSUs surrendered in lieu of taxes and cancelled awards returned to the 2013 Equity Incentive Plan. As a result, the Company paid taxes for restricted unit withholdings of approximately $14.2 million during the nine months ended September 30, 2023. (3) Includes AMC Preferred Equity Unit RSUs and PSUs that were converted to Common Stock RSUs and PSUs as a result of the Charter Amendments. |
Schedule of Stockholder's Equity | Preferred Stock Series A Convertible Accumulated Class A Voting Participating Depositary Shares of Additional Other Total Common Stock Preferred Stock AMC Preferred Paid-in Comprehensive Accumulated Stockholders’ (In millions, except share and per share data) Shares Amount Shares Equity Units Amount Capital Loss Deficit Equity (Deficit) Balances December 31, 2022 51,683,892 $ 0.5 7,245,872 72,458,706 $ 0.1 $ 5,049.8 $ (77.3) $ (7,597.6) $ (2,624.5) Net loss — — — — — — — (235.5) (235.5) Other comprehensive loss — — — — — — (7.3) — (7.3) Share issuance — — 492,880 4,928,800 — 70.5 — — 70.5 Antara Forward Purchase Agreement (2) — — 1,976,213 19,762,130 — 193.7 — — 193.7 Taxes paid for restricted unit withholdings — — — — — (13.1) — — (13.1) Stock-based compensation (1) 235,346 — 26,944 269,444 — 25.9 — — 25.9 Balances March 31, 2023 51,919,238 $ 0.5 9,741,909 97,419,080 $ 0.1 $ 5,326.8 $ (84.6) $ (7,833.1) $ (2,590.3) Net earnings — — — — — — — 8.6 8.6 Other comprehensive loss — — — — — — (40.0) — (40.0) Share issuance — — 212,156 2,121,562 — 32.7 — — 32.7 Taxes paid for restricted unit withholdings — — — — — (1.1) — — (1.1) Stock-based compensation — — — — — 7.5 — — 7.5 Balances June 30, 2023 51,919,238 $ 0.5 9,954,065 99,540,642 $ 0.1 $ 5,365.9 $ (124.6) $ (7,824.5) $ (2,582.6) Net loss — — — — — — — 12.3 12.3 Other comprehensive income — — — — — — 9.2 — 9.2 AMC Preferred Equity Unit conversion 99,540,642 1.0 (9,954,065) (99,540,642) (0.1) (0.9) — — — Settlement payment 6,897,018 0.1 — — — 99.2 — — 99.3 Share issuance 40,000,000 0.4 — — — 316.1 — — 316.5 Stock-based compensation — — — — — 7.3 — — 7.3 Balances September 30, 2023 198,356,898 $ 2.0 — — $ — $ 5,787.6 $ (115.4) $ (7,812.2) $ (2,138.0) (1) Includes 8,555 Common Stock shares and 15,370 AMC Preferred Equity Units awarded to the Board of Directors, 226,791 vested Common Stock RSUs and PSUs, and 254,074 AMC Preferred Equity Units RSUs and PSUs. (2) Includes $75.1 million of cash proceeds and $118.6 million carrying value of the debt exchanged for AMC Preferred Equity Units. Preferred Stock Series A Convertible Accumulated Class A Participating Depositary Shares of Additional Other Total AMC Common Stock Preferred Stock AMC Preferred Paid-in Comprehensive Accumulated Stockholders’ (In millions, except share and per share data) Shares Amount Shares Equity Units Amount Capital Income (Loss) Deficit Equity (Deficit) Balances December 31, 2021 51,397,910 $ 0.5 5,139,791 51,397,910 $ 0.1 $ 4,862.0 $ (28.1) $ (6,624.0) $ (1,789.5) Net loss — — — — — — — (337.4) (337.4) Other comprehensive loss — — — — — — (5.8) — (5.8) Taxes paid for restricted unit withholdings — — — — — (52.2) — — (52.2) Stock-based compensation (1) 284,150 0.1 28,415 284,150 — 6.5 — — 6.6 Balances March 31, 2022 51,682,060 $ 0.6 5,168,206 51,682,060 $ 0.1 $ 4,816.3 $ (33.9) $ (6,961.4) $ (2,178.3) Net loss — — — — — — — (121.6) (121.6) Other comprehensive income — — — — — — (46.3) — (46.3) Stock-based compensation — — — — — 19.4 — — 19.4 Balances June 30, 2022 51,682,060 $ 0.6 5,168,206 51,682,060 $ 0.1 $ 4,835.7 $ (80.2) $ (7,083.0) $ (2,326.8) Net loss — — — — — — — (226.9) (226.9) Other comprehensive loss — — — — — — (26.0) — (26.0) Share issuance — — 27,000 270,000 — 4.3 — — 4.3 Stock-based compensation — — — — — (3.6) — — (3.6) Balances September 30, 2022 51,682,060 $ 0.6 5,195,206 51,952,060 $ 0.1 $ 4,836.4 $ (106.2) $ (7,309.9) $ (2,579.0) (1) Includes 4,165 Common Stock shares and 4,165 AMC Preferred Equity Units awarded to Board of Directors, 279,985 vested Common Stock RSUs and PSUs, and 279,985 vested AMC Preferred Equity Units RSUs and PSUs. |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
FAIR VALUE MEASUREMENTS | |
Schedule of fair value hierarchy of financial assets carried at fair value on a recurring basis | Fair Value Measurements at September 30, 2023 Using Significant Total Carrying Quoted prices in Significant other unobservable Value at active market observable inputs inputs (In millions) September 30, 2023 (Level 1) (Level 2) (Level 3) Other long-term assets: Investment in Hycroft warrants $ 3.8 $ — $ — $ 3.8 Marketable equity securities: Investment in Hycroft 7.0 7.0 — — Total assets at fair value $ 10.8 $ 7.0 $ — $ 3.8 |
Schedule of fair value of financial instruments not recognized at fair value for which it is practicable to estimate fair value | Fair Value Measurements at September 30, 2023 Using Significant other Significant Total Carrying Quoted prices in observable unobservable Value at active market inputs inputs (In millions) September 30, 2023 (Level 1) (Level 2) (Level 3) Current maturities of corporate borrowings $ 20.0 $ — $ 16.2 $ — Corporate borrowings 4,750.4 — 3,542.5 — |
OPERATING SEGMENTS (Tables)
OPERATING SEGMENTS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
OPERATING SEGMENTS. | |
Schedule of financial information by reportable operating segment | Three Months Ended Nine Months Ended Revenues (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 1,063.9 $ 753.3 $ 2,855.8 $ 2,224.3 International markets 342.0 215.1 852.4 696.2 Total revenues $ 1,405.9 $ 968.4 $ 3,708.2 $ 2,920.5 Three Months Ended Nine Months Ended Adjusted EBITDA (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 150.6 $ 1.2 $ 336.3 $ 52.2 International markets 43.1 (14.1) 47.0 (20.1) Total Adjusted EBITDA $ 193.7 $ (12.9) $ 383.3 $ 32.1 (1) The Company presents Adjusted EBITDA as a supplemental measure of its performance. The Company defines Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that the Company does not consider indicative of the Company’s ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in International markets and any cash distributions of earnings from its other equity method investees. The measure of segment profit and loss the Company uses to evaluate performance and allocate its resources is Adjusted EBITDA, which is broadly consistent with how Adjusted EBITDA is defined in the Company’s debt indentures. Three Months Ended Nine Months Ended Capital Expenditures (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 U.S. markets $ 40.8 $ 40.1 $ 112.2 $ 91.5 International markets 16.7 14.4 41.3 38.2 Total capital expenditures $ 57.5 $ 54.5 $ 153.5 $ 129.7 |
Schedule of information about the Company's revenues from continuing operations and assets by geographic area | As of As of Long-term assets, net (In millions) September 30, 2023 December 31, 2022 U.S. markets $ 5,854.1 $ 6,135.9 International markets 1,958.9 2,097.6 Total long-term assets $ 7,813.0 $ 8,233.5 (1) Long-term assets are comprised of property, net, operating lease right-of-use assets, intangible assets, goodwill, deferred tax assets, net and other long-term assets. |
Schedule of reconciliation of net earnings to Adjusted EBITDA | The following table sets forth a reconciliation of net loss to Adjusted EBITDA: Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Net earnings (loss) $ 12.3 $ (226.9) $ (214.6) $ (685.9) Plus: Income tax provision 2.3 1.8 4.6 2.5 Interest expense 103.7 95.7 307.4 278.4 Depreciation and amortization 88.7 96.9 279.1 293.0 Certain operating expense 3.8 4.3 4.0 10.5 Equity in (earnings) loss of non-consolidated entities (3.1) (2.8) (5.3) 3.3 Cash distributions from non-consolidated entities 2.2 3.4 3.9 5.0 Attributable EBITDA 1.4 0.1 1.6 0.1 Investment expense (income) (3.0) 18.3 (11.4) 12.2 Other expense (income) (14.1) 6.2 (1.4) 110.9 Other non-cash rent benefit (8.4) (6.6) (27.0) (20.6) General and administrative — unallocated: Merger, acquisition and other costs 0.7 0.3 1.5 0.4 Stock-based compensation expense 7.2 (3.6) 40.9 22.3 Adjusted EBITDA $ 193.7 $ (12.9) $ 383.3 $ 32.1 (1) Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens, including the related accretion of interest, disposition of assets and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature or are non-operating in nature. (2) Includes U.S. non-theatre distributions from equity method investments and International non- theatre distributions from equity method investments to the extent received. The Company believes including cash distributions is an appropriate reflection of the contribution of these investments to the Company’s operations. (3) Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain International markets. See below for a reconciliation of the Company’s equity in loss of non-consolidated entities to attributable EBITDA. Because these equity investments in theatre operators are in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. The Company also provides services to these theatre operators including information technology systems, certain on-screen advertising services and the Company’s gift card and package ticket program. Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Equity in (earnings) loss of non-consolidated entities $ (3.1) $ (2.8) $ (5.3) $ 3.3 Less: Equity in (earnings) of non-consolidated entities excluding International theatre joint ventures (2.1) (3.5) (4.7) (3.1) Equity in earnings (loss) of International theatre joint ventures 1.0 (0.7) 0.6 (6.4) Income tax provision (benefit) 0.1 0.1 (0.1) 0.1 Investment expense (income) (0.2) — (0.1) 0.2 Interest expense 0.1 — 0.2 — Impairment of long-lived assets — — — 4.2 Depreciation and amortization 0.4 0.7 1.0 2.0 Attributable EBITDA $ 1.4 $ 0.1 $ 1.6 $ 0.1 (4) Investment expense (income) during the three months ended September 30, 2023 primarily includes appreciation in estimated fair value of the Company’s investment in common shares of Hycroft of $(0.1) million, deterioration in estimated fair value of the Company’s investment in warrants to purchase common shares of Hycroft of $0.8 million and interest income of $(3.7) million. During the three months ended September 30, 2022, investment expense (income) included deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $11.8 million, deterioration in estimated fair value of the Company's investment in warrants to purchase common shares of Hycroft of $7.7 million, and $1.6 million decline in estimated fair value of the Company’s investment in NCM Common Units, partially offset by interest income of $(2.8) million. Investment expense (income) during the nine months ended September 30, 2023 includes deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $5.4 million, deterioration in estimated fair value of the Company’s investment in warrants to purchase common shares of Hycroft of $5.4 million, $1.8 million of expense for NCM Common Units, $(15.5) million gain on the sale of the Company’s investment in Saudi Cinema Company, LLC and interest income of $(8.5) million. During the nine months ended September 30, 2022, investment expense (income) included deterioration in estimated fair value of the Company’s investment in common shares of Hycroft of $10.8 million, $11.1 million decline in estimated fair value of the Company’s investment in NCM Common Units, partially offset by appreciation in estimated fair value of the Company’s investment to purchase common shares of Hycroft of $(7.4) million and interest income of $(3.3) million. (5) Other expense (income) during the three months ended September 30, 2023 includes a non-cash litigation adjustment of $(16.1) million, income related to foreign currency transaction losses of $12.8 million and gains on debt extinguishment of $(10.8) million. During the three months ended September 30, 2022, other expense (income) included foreign currency transaction losses of $6.3 million. Other expense (income) during the nine months ended September 30, 2023 includes a non-cash litigation charge of $99.3 million, partially offset by gains on debt extinguishment of $(97.5) million and foreign currency transaction gains of $(3.2) million. During the nine months ended September 30, 2022, other expense (income) included loss on debt extinguishment of $96.4 million and foreign currency transaction losses of $14.7 million. (6) Reflects amortization expense for certain intangible assets reclassified from depreciation and amortization to rent expense due to the adoption of ASC 842, Leases and deferred rent benefit related to the impairment of right-of-use operating lease assets. (7) Merger, acquisition and other costs are excluded as they are non-operating in nature. (8) Non-cash or non-recurring expense included in general and administrative: other. |
EARNINGS (LOSS) PER SHARE (Tabl
EARNINGS (LOSS) PER SHARE (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
EARNINGS (LOSS) PER SHARE | |
Schedule of computation of basic and diluted earnings (loss) per common share | Three Months Ended Nine Months Ended (In millions) September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Numerator: Net earnings (loss) for basic earnings (loss) per share $ 12.3 $ (226.9) $ (214.6) $ (685.9) Net earnings (loss) for diluted earnings (loss) per share $ 12.3 $ (226.9) $ (214.6) $ (685.9) Denominator Weighted average shares for basic earnings (loss) per common share 162,424 103,369 150,465 103,306 Common equivalent shares for RSUs and PSUs 183 — — — Weighted average shares for diluted earnings (loss) per common share 162,607 103,369 150,465 103,306 Basic earnings (loss) per common share $ 0.08 $ (2.20) $ (1.43) $ (6.64) Diluted earnings (loss) per common share $ 0.08 $ (2.20) $ (1.43) $ (6.64) |
BASIS OF PRESENTATION - Liquidi
BASIS OF PRESENTATION - Liquidity (Details) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||||
Aug. 24, 2023 | Feb. 07, 2023 USD ($) shares | Dec. 22, 2022 USD ($) shares | Aug. 04, 2022 shares | Sep. 30, 2023 USD ($) | Jun. 30, 2023 USD ($) | Mar. 31, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) shares | Sep. 30, 2022 USD ($) | |
BASIS OF PRESENTATION | ||||||||||
Common stock dividend declared | shares | 1 | |||||||||
Number of shares issued | shares | 40,000,000 | |||||||||
Net proceeds from AMC Preferred Equity Units issuance | $ 492.4 | $ 7.8 | ||||||||
Increase in stockholders' deficit | $ 316.5 | $ 32.7 | $ 70.5 | $ 4.3 | ||||||
Conversion ratio | 0.1 | |||||||||
Stock split conversion ratio | 0.1 | |||||||||
Amount of minimum liquidity requirements | $ 100 | 100 | ||||||||
Accrued interest paid | 290 | $ 254.5 | ||||||||
Other Third Party Stock Issuance Costs Incurred | 0.5 | |||||||||
Gross proceeds | 325.5 | |||||||||
Sales agents fees paid | 8.2 | |||||||||
Payment to issuance cost to third party | $ 0.1 | |||||||||
Percentage of north american box office grosses | 0.16 | |||||||||
Second Lien Notes due 2026 | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares sold | shares | 9,102,619 | |||||||||
Value of shares sold | $ 100 | |||||||||
Cash interest rate (as a percent) | 10% | |||||||||
PIK interest rate (as a percent) | 12% | |||||||||
Aggregate principal amount | $ 100 | |||||||||
Second Lien Notes due 2026 | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Cash interest rate (as a percent) | 10% | |||||||||
PIK interest rate (as a percent) | 12% | |||||||||
Increase in stockholders' deficit | $ 193.7 | |||||||||
Aggregate principal amount | 100 | |||||||||
Accrued interest paid | 1.4 | |||||||||
AMC Preferred Equity Units | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Net proceeds from AMC Preferred Equity Units issuance | $ 75.1 | 75.1 | ||||||||
AMC Preferred Equity Units | Second Lien Notes due 2026 | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares issued | shares | 19,762,130 | |||||||||
AMC Preferred Equity Units | Second Lien Notes due 2026 | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares issued | shares | 19,762,130 | |||||||||
Forward purchase agreement | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares sold | shares | 10,659,511 | |||||||||
Value of shares sold | $ 75.1 | |||||||||
Increase in stockholders' deficit | $ 193.7 | |||||||||
At the Market Offerings | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares issued | shares | 40,000,000 | |||||||||
Other Third Party Stock Issuance Costs Incurred | $ 0.5 | |||||||||
Gross proceeds | 325.5 | |||||||||
Sales agents fees paid | 8.2 | |||||||||
Payment to issuance cost to third party | $ 0.1 | |||||||||
At the Market Offerings | AMC Preferred Equity Units | ||||||||||
BASIS OF PRESENTATION | ||||||||||
Number of shares issued | shares | 7,100,000 | |||||||||
Other Third Party Stock Issuance Costs Incurred | $ 8.7 | |||||||||
Gross proceeds | 114.5 | |||||||||
Sales agents fees paid | 2.9 | |||||||||
Payment to issuance cost to third party | $ 11.5 |
BASIS OF PRESENTATION - Debt re
BASIS OF PRESENTATION - Debt repurchase transactions (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Debt Instrument [Line Items] | ||
Gain on Extinguishment | $ 97.5 | $ (96.4) |
Senior Subordinated Notes 5.875 Due 2026 [Member] | ||
Debt Instrument [Line Items] | ||
Stated interest rate (as a percent) | 5.875% | |
Related And Non Related Parties [Member] | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | $ 169.7 | |
Reacquisition Cost | 101.5 | |
Gain on Extinguishment | 97.5 | |
Accrued Interest Paid | 3.4 | |
Related Party | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | 80 | |
Reacquisition Cost | 50.2 | |
Gain on Extinguishment | 43.2 | |
Accrued Interest Paid | 1.2 | |
Nonrelated Party [Member] | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | 89.7 | |
Reacquisition Cost | 51.3 | |
Gain on Extinguishment | 54.3 | |
Accrued Interest Paid | 2.2 | |
Second Lien Notes due 2026 | Related Party | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | 75.9 | |
Reacquisition Cost | 48.5 | |
Gain on Extinguishment | 40.9 | |
Accrued Interest Paid | 1.1 | |
Second Lien Notes due 2026 | Nonrelated Party [Member] | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | 89.7 | |
Reacquisition Cost | 51.3 | |
Gain on Extinguishment | 54.3 | |
Accrued Interest Paid | 2.2 | |
5.875% Senior Subordinated Notes due 2026 | Related Party | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Repurchased Face Amount | 4.1 | |
Reacquisition Cost | 1.7 | |
Gain on Extinguishment | 2.3 | |
Accrued Interest Paid | $ 0.1 |
BASIS OF PRESENTATION - Princip
BASIS OF PRESENTATION - Principles of Consolidation (Details) | 9 Months Ended |
Sep. 30, 2023 segment | |
BASIS OF PRESENTATION | |
Number of reportable segments | 2 |
BASIS OF PRESENTATION - Cash an
BASIS OF PRESENTATION - Cash and equivalents (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 729.7 | $ 631.5 |
U.S. | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | 620.7 | 508 |
International markets. | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 109 | $ 123.5 |
BASIS OF PRESENTATION - Restric
BASIS OF PRESENTATION - Restricted Cash (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Dec. 31, 2021 |
BASIS OF PRESENTATION | ||||
Cash and cash equivalents | $ 729.7 | $ 631.5 | ||
Restricted cash | 22.4 | 22.9 | ||
Total cash and cash equivalents and restricted cash in the statement of cash flows | $ 752.1 | $ 654.4 | $ 705.8 | $ 1,620.3 |
BASIS OF PRESENTATION - AOCL an
BASIS OF PRESENTATION - AOCL and Accumulated Depreciation and Amortization (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Accumulated other comprehensive loss | ||
Balance at the beginning of the period | $ (2,624.5) | |
Balance at the end of the period | (2,138) | |
Accumulated depreciation and amortization | ||
Accumulated depreciation | 2,994.3 | $ 2,853.8 |
Accumulated amortization | 16.1 | $ 22.2 |
Foreign Currency | ||
Accumulated other comprehensive loss | ||
Balance at the beginning of the period | (78.8) | |
Other comprehensive loss | (38.1) | |
Balance at the end of the period | (116.9) | |
Pension Benefits | ||
Accumulated other comprehensive loss | ||
Balance at the beginning of the period | 1.5 | |
Balance at the end of the period | 1.5 | |
Accumulated Other Comprehensive Income (Loss) | ||
Accumulated other comprehensive loss | ||
Balance at the beginning of the period | (77.3) | |
Other comprehensive loss | (38.1) | |
Balance at the end of the period | $ (115.4) |
BASIS OF PRESENTATION - Other E
BASIS OF PRESENTATION - Other Expense (Income) (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | $ (97.5) | $ 96.4 | ||
Shareholder litigation | $ (16.1) | 99.3 | ||
Business interruption insurance recoveries | $ (1.3) | |||
Gain on Business Interruption Insurance Recovery, Statement of Income or Comprehensive Income [Extensible Enumeration] | Total other expense (income) | Total other expense (income) | Total other expense (income) | Total other expense (income) |
Total other expense (income) | $ (12.8) | $ (1) | $ (4.7) | $ 91.6 |
Other expense | ||||
Other Expense (Income): | ||||
Decreases related to contingent lease guarantees | (0.1) | (0.2) | ||
Governmental assistance due to COVID-19- International markets | (5.4) | (16.2) | ||
Governmental assistance due to COVID-19 - U.S. markets | (1.6) | (2.7) | ||
Foreign currency transaction (gains) losses | 12.8 | 6.3 | (3.2) | 14.7 |
Non-operating components of net periodic benefit cost (income) | 0.5 | $ (0.2) | 1.2 | (0.4) |
Derivative stockholder settlement | (14) | |||
Shareholder litigation | (15.3) | 110.1 | ||
Other expense | Senior Subordinated Notes 5.875 Due 2026 [Member] | ||||
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | (2.3) | |||
Other expense | Second Lien Notes due 2026 | ||||
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | $ (10.8) | $ (95.2) | (38.6) | |
Other expense | First Lien Toggle Notes due 2026 | ||||
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | 32.9 | |||
Other expense | First Lien Notes due 2025 | ||||
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | 47.7 | |||
Other expense | First Lien Notes due 2026 | ||||
Other Expense (Income): | ||||
(Gain) loss on extinguishment of debt | $ 54.4 |
LEASES - Deferred payment (Deta
LEASES - Deferred payment (Details) $ in Millions | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Fixed operating lease deferred amounts included in: | |
Fixed operating lease deferred amounts, Beginning | $ 150.3 |
Fixed operating lease deferred amounts, Activity | (80) |
Fixed operating lease deferred amounts, Ending | 70.3 |
Finance lease deferred amounts included in: | |
Finance lease deferred amounts, Beginning | 0.9 |
Finance lease deferred amounts, Activity | (0.7) |
Finance lease deferred amounts, Ending | 0.2 |
Variable lease deferred amounts included in: | |
Variable lease deferred amounts, Beginning | 6 |
Variable lease deferred amounts, Activity | (2.3) |
Variable lease deferred amounts, Ending | 3.7 |
Total deferred lease amounts, Beginning | 157.2 |
Total deferred lease amounts, Activity | (83) |
Total deferred lease amounts, Ending | 74.2 |
Fixed operating lease deferred amounts | 13.3 |
Operating lease deferred fixed rent payments included in deferred and other non cash rent | $ 66.7 |
LEASES - Lease costs (Details)
LEASES - Lease costs (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Lessee, Lease, Description [Line Items] | ||||
Interest expense on lease liabilities | $ 0.9 | $ 1 | $ 2.8 | $ 3.2 |
Total lease cost | 250.3 | 243.6 | 723.7 | 734.2 |
Depreciation and amortization | ||||
Lessee, Lease, Description [Line Items] | ||||
Amortization of finance lease assets | 0.5 | 0.6 | 1.5 | 2 |
Finance lease obligations | ||||
Lessee, Lease, Description [Line Items] | ||||
Interest expense on lease liabilities | 0.9 | 0.9 | 2.8 | 3.1 |
60 Theatres | Rent | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease cost | 201.3 | 202 | 587.5 | 608.9 |
Variable lease cost | 23 | 21.2 | 63.3 | 59.9 |
60 Theatres | Operating expense (income) | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease cost | 0.6 | 1.5 | 1.2 | 4.1 |
Equipment | Operating expense (income) | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease cost | 4.8 | 2.7 | 11.8 | 7.4 |
Variable lease cost | 17.9 | 13.4 | 51.6 | 44.8 |
Office And Other | General and administrative: other | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease cost | $ 1.3 | $ 1.3 | $ 4 | $ 4 |
LEASES - Cash flow and suppleme
LEASES - Cash flow and supplemental information (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows used in finance leases | $ (2.3) | $ (2.9) |
Operating cash flows used in operating leases | (742.5) | (775.9) |
Financing cash flows used in finance leases | (4.6) | (7.9) |
Landlord contributions: | ||
Operating cashflows provided by operating leases | 16 | 16.2 |
Supplemental disclosure of noncash leasing activities: | ||
Right-of-use assets obtained in exchange for new operating lease liabilities (1) | $ 111.4 | $ 220.8 |
LEASES - Lease terms and discou
LEASES - Lease terms and discount rates (Details) | Sep. 30, 2023 |
LEASES | |
Operating leases, weighted average remaining lease term | 8 years 10 months 24 days |
Finance leases, weighted average remaining lease term | 13 years 4 months 24 days |
Operating leases, weighted average discount rate | 10.40% |
Finance leases, weighted average discount rate | 6.40% |
LEASES - Minimum annual payment
LEASES - Minimum annual payments under leases (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Operating Lease Payments | ||
Three months ending December 31, 2023 | $ 241.7 | |
2024 | 891.2 | |
2025 | 847.1 | |
2026 | 781.7 | |
2027 | 717.1 | |
2028 | 633.5 | |
Thereafter | 2,736.9 | |
Total lease payments | 6,849.2 | |
Less imputed interest | (2,357.2) | |
Total operating and finance lease liabilities, respectively | 4,492 | |
Financing Lease Payments | ||
Three months ending December 31, 2023 | 2.2 | |
2024 | 8.1 | |
2025 | 7.4 | |
2026 | 7.3 | |
2027 | 7.3 | |
2028 | 6.9 | |
Thereafter | 44.4 | |
Total lease payments | 83.6 | |
Less imputed interest | (29.1) | |
Total operating and finance lease liabilities, respectively | $ 54.5 | $ 58.8 |
LEASES - Accounts Payable Lease
LEASES - Accounts Payable Lease Payments (Details) $ in Millions | Sep. 30, 2023 USD ($) |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | $ 8.7 |
Three months ended December 31, 2023 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 5.7 |
2024 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 1 |
2025 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 0.8 |
2026 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 0.7 |
2027 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 0.3 |
2028 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | 0.1 |
Thereafter | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts recorded in accounts payable | $ 0.1 |
LEASES - Deferred lease (Detail
LEASES - Deferred lease (Details) $ in Millions | Sep. 30, 2023 USD ($) |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | $ 65.4 |
Total deferred lease amounts, finance lease payments | 0.1 |
Three months ended December 31, 2023 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 15.6 |
Total deferred lease amounts, finance lease payments | 0.1 |
2024 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 15.6 |
2025 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 5.7 |
2026 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 4.2 |
2027 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 3.4 |
2028 | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | 3.2 |
Thereafter | |
Lessee, Lease, Description [Line Items] | |
Total deferred lease amounts, operating lease payment | $ 17.7 |
LEASES - Future lease agreement
LEASES - Future lease agreements (Details) $ in Millions | 9 Months Ended |
Sep. 30, 2023 USD ($) item | |
Signed lease agreements | $ | $ 78.2 |
Future Lease Commitments | |
Number of Theatres | item | 5 |
Lease buyout incentive | $ | $ 13 |
Lease, right to terminate by landlord, number of theatre | item | 1 |
Minimum | Future Lease Commitments | |
Initial base terms of operating leases | 10 years |
Maximum | Future Lease Commitments | |
Initial base terms of operating leases | 20 years |
REVENUE RECOGNITION - Disaggreg
REVENUE RECOGNITION - Disaggregation of revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 1,405.9 | $ 968.4 | $ 3,708.2 | $ 2,920.5 |
Products and services transferred at point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 1,299.3 | 884.5 | 3,431.5 | 2,675.3 |
Products and services transferred over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 106.6 | 83.9 | 276.7 | 245.2 |
Admissions | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 797.7 | 545.3 | 2,075.9 | 1,640.1 |
Food and beverage | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 482.7 | 333.3 | 1,299.6 | 982.5 |
Other theatre | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 125.5 | 89.8 | 332.7 | 297.9 |
Screen advertising | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 33.2 | 29 | 96.4 | 90.2 |
Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 92.3 | $ 60.8 | $ 236.3 | $ 207.7 |
REVENUE RECOGNITION - Receivabl
REVENUE RECOGNITION - Receivables and deferred revenue (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets | ||
Receivables related to contracts with customers | $ 54.4 | $ 92.3 |
Miscellaneous receivables | 79.8 | 74.3 |
Receivables, net | 134.2 | 166.6 |
Current liabilities | ||
Deferred revenue related to contracts with customers | 405.7 | 398.8 |
Miscellaneous deferred income | 5.3 | 3.9 |
Deferred revenues and income | $ 411 | $ 402.7 |
REVENUE RECOGNITION - Changes i
REVENUE RECOGNITION - Changes in liabilities (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Apr. 11, 2023 | |
Deferred revenues related to contracts with customers | ||
Beginning balance | $ 398.8 | |
Cash received in advance | 248.5 | |
Foreign currency translation adjustment | 0.5 | |
Ending balance | 405.7 | |
National CineMedia Inc. | ||
Deferred revenues related to contracts with customers | ||
Number of common unit issuance | 16,581,829 | |
Exhibitor Services Agreement | ||
Deferred revenues related to contracts with customers | ||
Beginning balance | 505.8 | |
Reclassification to revenue as the result of performance obligations satisfied | (13.8) | |
Ending balance | $ 492 | |
Term of amortization of the exhibitor services agreement (ESA) with NCM | 30 years | |
Admissions | ||
Deferred revenues related to contracts with customers | ||
Customer loyalty awards accumulated, net of expirations | $ 17.4 | |
Reclassification to revenue as the result of performance obligations satisfied | (197.8) | |
Food and beverage | ||
Deferred revenues related to contracts with customers | ||
Customer loyalty awards accumulated, net of expirations | 31.6 | |
Reclassification to revenue as the result of performance obligations satisfied | (58.7) | |
Other theatre | ||
Deferred revenues related to contracts with customers | ||
Customer loyalty awards accumulated, net of expirations | (0.7) | |
Reclassification to revenue as the result of performance obligations satisfied | $ (33.9) |
REVENUE RECOGNITION - Transacti
REVENUE RECOGNITION - Transaction price allocated to the remaining performance obligations (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Customer Frequency Program | ||
Deferred revenues and income | $ 411 | $ 402.7 |
Gift Card And Ticket Exchange | ||
Customer Frequency Program | ||
Redemption period | 24 months | |
Deferred revenues and income | $ 273.2 | |
Loyalty Program | ||
Customer Frequency Program | ||
Redemption period | 24 months | |
Deferred revenues and income | $ 75.6 |
GOODWILL (Details)
GOODWILL (Details) $ in Millions | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Gross Carrying Amount, Balance at the beginning of the period | $ 4,594.4 |
Accumulated Impairment Losses, Balance at the beginning of the period | (2,252.4) |
Net Carrying Amount, Balance at the beginning of the period | 2,342 |
Gross Carrying Amount, Currency translation adjustment | (23.6) |
Accumulated Impairment Losses, Currency translation adjustment | (7.6) |
Net Carrying Amount, Currency translation adjustment | (31.2) |
Gross Carrying Amount, Balance at the end of the period | 4,570.8 |
Accumulated Impairment Losses, Balance at the end of the period | (2,260) |
Net Carrying Amount, Balance at the end of the period | 2,310.8 |
U.S. Markets | |
Goodwill [Roll Forward] | |
Gross Carrying Amount, Balance at the beginning of the period | 3,072.6 |
Accumulated Impairment Losses, Balance at the beginning of the period | (1,276.1) |
Net Carrying Amount, Balance at the beginning of the period | 1,796.5 |
Gross Carrying Amount, Balance at the end of the period | 3,072.6 |
Accumulated Impairment Losses, Balance at the end of the period | (1,276.1) |
Net Carrying Amount, Balance at the end of the period | 1,796.5 |
International Markets | |
Goodwill [Roll Forward] | |
Gross Carrying Amount, Balance at the beginning of the period | 1,521.8 |
Accumulated Impairment Losses, Balance at the beginning of the period | (976.3) |
Net Carrying Amount, Balance at the beginning of the period | 545.5 |
Gross Carrying Amount, Currency translation adjustment | (23.6) |
Accumulated Impairment Losses, Currency translation adjustment | (7.6) |
Net Carrying Amount, Currency translation adjustment | (31.2) |
Gross Carrying Amount, Balance at the end of the period | 1,498.2 |
Accumulated Impairment Losses, Balance at the end of the period | (983.9) |
Net Carrying Amount, Balance at the end of the period | $ 514.3 |
INVESTMENTS (Details)
INVESTMENTS (Details) $ / shares in Units, ر.س in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||||||
Aug. 24, 2023 | Dec. 30, 2022 USD ($) | Dec. 30, 2022 SAR (ر.س) | Mar. 14, 2022 USD ($) $ / shares shares | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) item | Sep. 30, 2022 USD ($) | |
Investments | ||||||||
Gain on investment sold | $ 15.5 | |||||||
Recorded equity in (earnings) loss | $ 3.1 | $ 2.8 | $ 5.3 | $ (3.3) | ||||
Equity Method Investments Ownership Transactions [Abstract] | ||||||||
Stock split conversion ratio | 0.1 | |||||||
U.S. | ||||||||
Investments | ||||||||
Number of Theatres | item | 4 | |||||||
Europe | ||||||||
Investments | ||||||||
Number of Theatres | item | 60 | |||||||
Hycroft | ||||||||
Equity Method Investments Ownership Transactions [Abstract] | ||||||||
Cost of investment | $ 27.9 | |||||||
Number of shares purchased | shares | 23,400,000 | |||||||
Stock split conversion ratio | 1 | |||||||
Price per unit in equity method investment | $ / shares | $ 1.193 | |||||||
Number of shares to be received for each unit | shares | 1 | |||||||
Unrealized loss (gain) on investments | $ (10.8) | (3.4) | ||||||
Hycroft | Investment Income | ||||||||
Equity Method Investments Ownership Transactions [Abstract] | ||||||||
Unrealized loss (gain) on investments | $ 0.7 | 19.5 | $ 10.8 | 3.4 | ||||
60 Theatres | Europe | ||||||||
Investments | ||||||||
Ownership percentage | 50% | 50% | ||||||
Investment in Hycroft Mining Holding Corporation Warrants | ||||||||
Investments | ||||||||
Price per share (in dollars per share) | $ / shares | $ 1.068 | |||||||
Equity Method Investments Ownership Transactions [Abstract] | ||||||||
Number of shares to be received for each unit | shares | 1 | |||||||
Term | 5 years | |||||||
Non consolidated investee | ||||||||
Investments | ||||||||
Recorded equity in (earnings) loss | $ (3.1) | $ (2.8) | $ (5.3) | $ 3.3 | ||||
DCM | ||||||||
Investments | ||||||||
Ownership percentage | 50% | 50% | ||||||
SV Holdco | ||||||||
Investments | ||||||||
Ownership percentage | 18.40% | 18.40% | ||||||
AC JV, LLC | ||||||||
Investments | ||||||||
Ownership percentage | 32% | 32% | ||||||
SCC | ||||||||
Investments | ||||||||
Percentage of equity method investment sold | 10% | 10% | ||||||
Equity method investment, amount sold | $ 30 | ر.س 112.5 | ||||||
Gain on investment sold | $ 15.5 | |||||||
DCDC | ||||||||
Investments | ||||||||
Ownership percentage | 14.60% | 14.60% | ||||||
Maximum | Non consolidated investee | ||||||||
Investments | ||||||||
Ownership percentage | 50% | 50% |
INVESTMENTS - Related Party Tra
INVESTMENTS - Related Party Transactions (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Related Party Transactions | |||||
Operating expense, related party | $ 3.8 | $ 4.3 | $ 4 | $ 10.5 | |
Equity Method Investment, Nonconsolidated Investee(s) | Related Party | |||||
Related Party Transactions | |||||
Receivable due from related party | 0.6 | 0.6 | $ 1.7 | ||
Other revenues, related party | 7.9 | 4.3 | 19.4 | 16.3 | |
Film exhibition costs, related party | 4.9 | 3.1 | 12 | 6.5 | |
Operating expense, related party | $ 0.2 | $ 0.3 | $ 0.8 | $ 0.8 |
CORPORATE BORROWINGS AND FINA_3
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES - Long-term debt and lease obligations (Details) € in Millions, $ in Millions | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) | Sep. 30, 2023 EUR (€) | |
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 4,664.4 | $ 4,949 | |
Finance lease liabilities | 54.5 | 58.8 | |
Deferred financing costs | (33) | (37.9) | |
Net premium | 139 | 229.7 | |
Total carrying value of corporate borrowings and finance lease liabilities | 4,824.9 | 5,199.6 | |
Current maturities of corporate borrowings | 20 | 20 | |
Current maturities of finance lease liabilities | (6.2) | (5.5) | |
Total noncurrent carrying value of corporate borrowings and finance lease liabilities | 4,798.7 | 5,174.1 | |
6.375% Senior Subordinated Notes due 2024 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 4.9 | 4.8 | |
Net premium | $ 0.1 | ||
Stated interest rate (as a percent) | 6.375% | 6.375% | 6.375% |
Debt instrument face amount | € | € 4 | ||
5.75 % Senior Subordinated Notes due 2025 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 98.3 | $ 98.3 | |
Stated interest rate (as a percent) | 5.75% | 5.75% | 5.75% |
5.875% Senior Subordinated Notes due 2026 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 51.5 | $ 55.6 | |
Stated interest rate (as a percent) | 5.875% | 5.875% | 5.875% |
6.125% Senior Subordinated Notes due 2027 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 125.5 | $ 125.5 | |
Stated interest rate (as a percent) | 6.125% | 6.125% | 6.125% |
Odeon Senior Secured Note 2027 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Net premium | $ (27.7) | $ (31.1) | |
Stated interest rate (as a percent) | 12.75% | 12.75% | 12.75% |
Senior Secured Credit Facility Term-Loan Due 2026 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 1,910 | $ 1,925 | |
Net premium | $ (3.7) | $ (4.8) | |
Stated interest rate (as a percent) | 8.427% | 7.274% | 8.427% |
Odeon Senior Secured Notes Due 2027 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 400 | $ 400 | |
Stated interest rate (as a percent) | 12.75% | 12.75% | 12.75% |
First Lien Notes due 2029 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 950 | $ 950 | |
Stated interest rate (as a percent) | 7.50% | 7.50% | 7.50% |
Second Lien Subordinated Notes due 2026 | |||
CORPORATE BORROWINGS AND FINANCE LEASE OBLIGATIONS | |||
Total principal amount of corporate borrowings | $ 1,124.2 | $ 1,389.8 | |
Net premium | $ 170.4 | $ 265.5 | |
Interest rate cash (as a percent) | 10% | 10% | |
PIK interest rate (as a percent) | 12% | 12% |
CORPORATE BORROWINGS AND FINA_4
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES - Maturities of corporate borrowings (Details) $ in Millions | Sep. 30, 2023 USD ($) |
Principal Amount of Corporate Borrowings | |
Three months ended December 31, 2023 | $ 5 |
2024 | 24.9 |
2025 | 118.3 |
2026 | 3,040.7 |
2027 | 525.5 |
Thereafter | 950 |
Total | $ 4,664.4 |
CORPORATE BORROWINGS AND FINA_5
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES - Debt repurchase transactions (Details) - USD ($) $ in Millions | 7 Months Ended | 9 Months Ended | |
Aug. 25, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | |
Debt Instrument [Line Items] | |||
Gain on Extinguishment | $ 97.5 | $ (96.4) | |
Related and Non-Related parties | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 169.7 | ||
Reacquisition Cost | 101.5 | ||
Gain on Extinguishment | 97.5 | ||
Accrued Interest Paid | 3.4 | ||
Related Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 80 | ||
Reacquisition Cost | 50.2 | ||
Gain on Extinguishment | 43.2 | ||
Accrued Interest Paid | 1.2 | ||
Nonrelated Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 89.7 | ||
Reacquisition Cost | 51.3 | ||
Gain on Extinguishment | 54.3 | ||
Accrued Interest Paid | 2.2 | ||
Second Lien Notes due 2026 | Related Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 75.9 | ||
Reacquisition Cost | 48.5 | ||
Gain on Extinguishment | 40.9 | ||
Accrued Interest Paid | 1.1 | ||
Second Lien Notes due 2026 | Nonrelated Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 89.7 | ||
Reacquisition Cost | 51.3 | ||
Gain on Extinguishment | 54.3 | ||
Accrued Interest Paid | 2.2 | ||
Second Lien Notes due 2026 | Related party transactions | Antara Capital LP | Related Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | $ 100 | ||
Preferred equity | 9,102,619 | ||
5.875% Senior Subordinated Notes due 2026 | Related Party | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Repurchased | 4.1 | ||
Reacquisition Cost | 1.7 | ||
Gain on Extinguishment | 2.3 | ||
Accrued Interest Paid | $ 0.1 | ||
Stated interest rate (as a percent) | 5.875% |
CORPORATE BORROWINGS AND FINA_6
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES - Financial Covenants (Details) $ in Millions | Sep. 30, 2023 USD ($) |
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES | |
Minimum liquidity requirement | $ 100 |
CORPORATE BORROWINGS AND FINA_7
CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES - Thirteenth Amendment to Credit Agreement (Details) - Thirteenth Amendment to Credit Agreement | Jun. 23, 2023 |
SOFR, Interest period of one-month | |
Debt Instrument [Line Items] | |
Credit spread adjustment | 0.11448% |
SOFR, Interest period of three-months | |
Debt Instrument [Line Items] | |
Credit spread adjustment | 0.26161% |
SOFR, Interest period of six-months | |
Debt Instrument [Line Items] | |
Credit spread adjustment | 0.42826% |
STOCKHOLDERS' EQUITY (Details)
STOCKHOLDERS' EQUITY (Details) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||||||||||||||||
Aug. 28, 2023 shares | Aug. 25, 2023 shares | Aug. 24, 2023 | Aug. 11, 2023 | Apr. 02, 2023 | Mar. 14, 2023 shares | Feb. 23, 2023 shares | Feb. 07, 2023 USD ($) shares | Dec. 22, 2022 USD ($) shares | Aug. 04, 2022 shares | Sep. 30, 2023 USD ($) item shares | Jun. 30, 2023 USD ($) | Mar. 31, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) item shares | Sep. 30, 2022 USD ($) | Sep. 06, 2023 shares | Mar. 13, 2023 shares | Dec. 31, 2022 shares | Sep. 26, 2022 shares | Jan. 19, 2018 item | Jan. 12, 2018 item | |
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Common stock dividend declared | shares | 1 | |||||||||||||||||||||
Gross proceeds | $ 325.5 | |||||||||||||||||||||
Number of shares issued | shares | 40,000,000 | |||||||||||||||||||||
Sales agents fees paid | $ 8.2 | |||||||||||||||||||||
other third-party issuance | 0.5 | |||||||||||||||||||||
Payment to issuance cost to third party | 0.1 | |||||||||||||||||||||
Conversion ratio | 0.1 | |||||||||||||||||||||
Conversion of Convertible Securities into common stock | shares | 99,540,642 | |||||||||||||||||||||
Increase in stockholders' deficit | $ 316.5 | $ 32.7 | $ 70.5 | $ 4.3 | ||||||||||||||||||
Accrued interest paid | 290 | $ 254.5 | ||||||||||||||||||||
Net proceeds from AMC Preferred Equity Units issuance | $ 492.4 | $ 7.8 | ||||||||||||||||||||
Number of pending actions | item | 2 | 2 | 2 | 2 | ||||||||||||||||||
Shares issued during period of settlement payment | shares | 6,897,018 | |||||||||||||||||||||
Preferred stock, share authorized (in shares) | shares | 50,000,000 | 50,000,000 | 50,000,000 | |||||||||||||||||||
Stock split conversion ratio | 0.1 | |||||||||||||||||||||
Maximum | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Reserved for future issuance | shares | 40,000,000 | 42,500,000 | ||||||||||||||||||||
At the Market Offerings | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Gross proceeds | $ 325.5 | |||||||||||||||||||||
Number of shares issued | shares | 40,000,000 | |||||||||||||||||||||
Sales agents fees paid | $ 8.2 | |||||||||||||||||||||
other third-party issuance | 0.5 | |||||||||||||||||||||
Payment to issuance cost to third party | $ 0.1 | |||||||||||||||||||||
Forward purchase agreement | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Value of shares sold | $ 75.1 | |||||||||||||||||||||
Increase in stockholders' deficit | 193.7 | |||||||||||||||||||||
Number of shares sold | shares | 10,659,511 | |||||||||||||||||||||
Shareholder Litigation | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Stock split conversion ratio | 0.1333 | 0.1333 | ||||||||||||||||||||
AMC Preferred Equity Units | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Preferred stock, shares issued (in shares) | shares | 0 | 0 | 7,245,872 | |||||||||||||||||||
Net proceeds from AMC Preferred Equity Units issuance | $ 75.1 | $ 75.1 | ||||||||||||||||||||
Preferred stock, share authorized (in shares) | shares | 0 | 0 | 10,000,000 | |||||||||||||||||||
AMC Preferred Equity Units | At the Market Offerings | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Gross proceeds | $ 114.5 | |||||||||||||||||||||
Number of shares issued | shares | 7,100,000 | |||||||||||||||||||||
Sales agents fees paid | $ 2.9 | |||||||||||||||||||||
other third-party issuance | 8.7 | |||||||||||||||||||||
Payment to issuance cost to third party | $ 11.5 | |||||||||||||||||||||
Class A common stock | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Number of shares authorized | shares | 550,000,000 | 550,000,000 | 524,173,073 | |||||||||||||||||||
Special awards expense | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Expected performance target to be achieved (as a percent) | 200% | |||||||||||||||||||||
Special awards expense | AMC Preferred Equity Units | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Shares vested | shares | 238,959 | |||||||||||||||||||||
Special awards expense | Class A common stock | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Shares vested | shares | 238,959 | |||||||||||||||||||||
Special Meeting of Stockholders | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Number of shares authorized | shares | 550,000,000 | 524,173,073 | ||||||||||||||||||||
Stock split conversion ratio | 1 | |||||||||||||||||||||
Second Lien Notes due 2026 | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Value of shares sold | $ 100 | |||||||||||||||||||||
Conversion of Convertible Securities into common stock | shares | 9,102,619 | |||||||||||||||||||||
Debt instrument face amount | $ 100 | |||||||||||||||||||||
Cash interest rate (as a percent) | 10% | |||||||||||||||||||||
PIK interest rate (as a percent) | 12% | |||||||||||||||||||||
Number of shares sold | shares | 9,102,619 | |||||||||||||||||||||
Second Lien Notes due 2026 | AMC Preferred Equity Units | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Number of shares issued | shares | 19,762,130 | |||||||||||||||||||||
Second Lien Notes due 2026 | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Debt instrument face amount | $ 100 | |||||||||||||||||||||
Cash interest rate (as a percent) | 10% | |||||||||||||||||||||
PIK interest rate (as a percent) | 12% | |||||||||||||||||||||
Increase in stockholders' deficit | $ 193.7 | |||||||||||||||||||||
Accrued interest paid | $ 1.4 | |||||||||||||||||||||
Second Lien Notes due 2026 | AMC Preferred Equity Units | ||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||||||||||||
Number of shares issued | shares | 19,762,130 |
STOCKHOLDERS' EQUITY - Stock-ba
STOCKHOLDERS' EQUITY - Stock-based compensation (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Feb. 23, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Stock Based Compensation Expense | |||||
Stock-based compensation expense | $ 7.2 | $ (3.6) | $ 40.9 | $ 22.3 | |
Total estimated unrecognized compensation cost related to nonvested stock-based compensation arrangements | 20.1 | $ 20.1 | |||
Weighted average period recognized | 1 year 1 month 6 days | ||||
Board of director stock award expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | $ 0.9 | 0.8 | |||
Equity Classified Awards | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | 7.3 | (3.6) | 40.6 | 22.3 | |
Special awards expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | 20.2 | ||||
Performance stock unit expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | 3.6 | (7.1) | 9 | 11.7 | |
Restricted stock unit expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | 3.7 | $ 3.5 | 10.5 | $ 9.8 | |
Liability classified awards | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | (0.1) | 0.3 | |||
Restricted and performance stock unit expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | $ (0.1) | $ 0.3 | |||
Class A common stock | Special awards expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | $ 14.9 | ||||
AMC Preferred Equity Units | Special awards expense | |||||
Stock Based Compensation Expense | |||||
Stock-based compensation expense | $ 5.3 |
STOCKHOLDERS' EQUITY - Awards g
STOCKHOLDERS' EQUITY - Awards granted (Details) $ in Millions | 9 Months Ended | |
Aug. 25, 2023 shares | Sep. 30, 2023 USD ($) tranche shares | |
STOCKHOLDERS' EQUITY | ||
Conversion of share based payment awards into preferred stock | 1 | |
Conversion of Convertible Securities into common stock | 99,540,642 | |
Conversion ratio of share based payment awards into common stock | 1 | |
2023 Performance share award | ||
STOCKHOLDERS' EQUITY | ||
Granted (in shares) | 95,883 | |
Stock value | $ | $ 3.9 | |
2022 Performance share award | ||
STOCKHOLDERS' EQUITY | ||
Granted (in shares) | 46,192 | |
Stock value | $ | $ 1.9 | |
2021 Performance share award | ||
STOCKHOLDERS' EQUITY | ||
Granted (in shares) | 160,280 | |
Stock value | $ | $ 6.8 | |
Percentage of performance target | 100% | |
Restricted stock unit | Members of management and executive officers | ||
STOCKHOLDERS' EQUITY | ||
Number of shares to be received for each unit | 1 | |
Performance Vesting | Members of management and executive officers | ||
STOCKHOLDERS' EQUITY | ||
Granted (in shares) | 287,664 | |
Number of tranches | tranche | 3 | |
Awards to be granted if target not achieved (in shares) | 0 | |
Performance Vesting | Members of management and executive officers | Minimum | ||
STOCKHOLDERS' EQUITY | ||
PSUs vesting as a percentage of performance target | 80% | |
Percentage of performance target | 50% | |
Performance Vesting | Members of management and executive officers | Maximum | ||
STOCKHOLDERS' EQUITY | ||
PSUs vesting as a percentage of performance target | 120% | |
Percentage of performance target | 200% | |
2013 Equity Incentive Plan | ||
STOCKHOLDERS' EQUITY | ||
Conversion of Convertible Securities into common stock | 1 | |
2013 Equity Incentive Plan | Members of management | ||
STOCKHOLDERS' EQUITY | ||
Granted (in shares) | 313,831 | |
Grant date fair value (in dollars) | $ | $ 12 | |
Vesting period (in years) | 3 years | |
Vesting rights percentage | 33.33% | |
2013 Equity Incentive Plan | Employee Stock Option [Member] | Board of Directors | ||
STOCKHOLDERS' EQUITY | ||
Shares granted | 8,555 | |
Grant date fair value | $ | $ 0.9 | |
2013 Equity Incentive Plan | Restricted stock unit | Members of management | ||
STOCKHOLDERS' EQUITY | ||
Number of days for settlement | 30 days | |
2013 Equity Incentive Plan | Performance Vesting | Members of management and executive officers | ||
STOCKHOLDERS' EQUITY | ||
Percentage of performance target | 100% | |
Awards to be granted upon achieving 100% of performance target (in shares) | 287,664 | |
AMC Preferred Equity Units | RSU and PSU Units | ||
STOCKHOLDERS' EQUITY | ||
Nonvested shares | 169,401 | |
AMC Preferred Equity Units | RSU and PSU Units | 2023 Tranche Year | ||
STOCKHOLDERS' EQUITY | ||
Nonvested shares | 112,894 | |
AMC Preferred Equity Units | RSU and PSU Units | 2024 & 2025 Tranche Year | ||
STOCKHOLDERS' EQUITY | ||
Nongranted shares | 56,507 | |
AMC Preferred Equity Units | 2013 Equity Incentive Plan | Board of Directors | ||
STOCKHOLDERS' EQUITY | ||
Shares granted | 15,370 |
STOCKHOLDERS' EQUITY - RSU, PSU
STOCKHOLDERS' EQUITY - RSU, PSU and SPSU activity (Details) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Weighted Average Grant Date Fair Value | ||
Taxes paid for restricted unit withholdings | $ 14.2 | $ 52.2 |
RSU and PSU | ||
Weighted Average Grant Date Fair Value | ||
Taxes paid for restricted unit withholdings | $ 14.2 | |
RSU and PSU | Class A common stock | ||
Shares of RSU PSU and SPSU | ||
Nonvested at January 1, 2023 (in shares) | 626,195 | |
Granted (in shares) | 616,186 | |
Vested (in shares) | (222,920) | |
Forfeited (in shares) | (26,036) | |
Cancelled (in shares) | (150,755) | |
Nonvested at September 30, 2023 (in shares) | 842,670 | |
Weighted Average Grant Date Fair Value | ||
Nonvested at January 1, 2023 (in dollars per share) | $ 59.14 | |
Granted (in dollars per share) | 39.99 | |
Vested (in dollars per share) | 57.43 | |
Forfeited (in dollars per share) | 44.44 | |
Cancelled (in dollars per share) | 60.14 | |
Nonvested at September 30, 2023 (in dollars per share) | $ 45.87 | |
Tranche Years 2024 and 2025 awarded under the 2023 PSU award and Tranche Year 2024 awarded under the 2022 PSU award with grant date fair values to be determined in years 2024 and 2025, respectively | 228,199 | |
Total Nonvested at September 30, 2023 | 1,070,869 | |
RSU and PSU | Special Award | Class A common stock | ||
Shares of RSU PSU and SPSU | ||
Granted (in shares) | 477,918 | |
Vested (in shares) | (257,945) | |
Cancelled | (219,973) | |
Weighted Average Grant Date Fair Value | ||
Granted (in dollars per share) | $ 42.25 | |
Vested (in dollars per share) | 42.18 | |
Cancelled (in dollars per share) | $ 42.34 | |
Special Performance Stock | Cumulative Adjusted EBITDA Target | ||
Weighted Average Grant Date Fair Value | ||
Percentage of performance target | 100% | |
Special Performance Stock | Cumulative Adjusted Free Cash Flow Target | ||
Weighted Average Grant Date Fair Value | ||
Percentage of performance target | 100% |
STOCKHOLDERS' EQUITY - Equity s
STOCKHOLDERS' EQUITY - Equity statements (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||||||||
Aug. 25, 2023 | Feb. 07, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | $ (2,582.6) | $ (2,590.3) | $ (2,624.5) | $ (2,326.8) | $ (2,178.3) | $ (1,789.5) | $ (2,624.5) | $ (1,789.5) | |||
Net earnings (loss) | 12.3 | 8.6 | (235.5) | (226.9) | (121.6) | (337.4) | $ (214.6) | (685.9) | |||
Other comprehensive loss | 9.2 | (40) | (7.3) | (26) | (46.3) | (5.8) | |||||
AMC Preferred Equity Unit conversion (in shares) | 99,540,642 | ||||||||||
Settlement payment | 99.3 | ||||||||||
Share issuance | 316.5 | 32.7 | 70.5 | 4.3 | |||||||
Share issuance (in shares) | 40,000,000 | ||||||||||
Taxes paid for restricted unit withholdings | (1.1) | (13.1) | (52.2) | ||||||||
Stock-based compensation | 7.3 | 7.5 | 25.9 | 19.4 | 6.6 | ||||||
Stock-based compensation | (3.6) | ||||||||||
Balance at the end of the period | (2,138) | (2,582.6) | (2,590.3) | (2,579) | (2,326.8) | $ (2,178.3) | $ (2,138) | (2,579) | |||
Net proceeds from AMC Preferred Equity Units issuance | 492.4 | 7.8 | |||||||||
Carrying value of corporate borrowings | 4,664.4 | 4,664.4 | $ 4,949 | ||||||||
Second Lien Notes due 2026 | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance | $ 193.7 | ||||||||||
Carrying value of corporate borrowings | 118.6 | ||||||||||
Forward purchase agreement | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance | $ 193.7 | ||||||||||
Board of Directors | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Shares awarded | 8,555 | 4,165 | |||||||||
RSUs and PSUs vested | 226,791 | 279,985 | |||||||||
Preferred Stock | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | 0.1 | 0.1 | $ 0.1 | 0.1 | 0.1 | $ 0.1 | 0.1 | 0.1 | |||
AMC Preferred Equity Unit conversion | (0.1) | ||||||||||
Balance at the end of the period | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Additional Paid-in Capital | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | 5,365.9 | 5,326.8 | 5,049.8 | 4,835.7 | 4,816.3 | 4,862 | 5,049.8 | 4,862 | |||
AMC Preferred Equity Unit conversion | (0.9) | ||||||||||
Settlement payment | 99.2 | ||||||||||
Share issuance | 316.1 | 32.7 | 70.5 | 4.3 | |||||||
Taxes paid for restricted unit withholdings | (1.1) | (13.1) | (52.2) | ||||||||
Stock-based compensation | 7.3 | 7.5 | 25.9 | 19.4 | 6.5 | ||||||
Stock-based compensation | (3.6) | ||||||||||
Balance at the end of the period | 5,787.6 | 5,365.9 | 5,326.8 | 4,836.4 | 4,835.7 | 4,816.3 | 5,787.6 | 4,836.4 | |||
Additional Paid-in Capital | Forward purchase agreement | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance | 193.7 | ||||||||||
Accumulated Other Comprehensive Income (Loss) | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | (124.6) | (84.6) | (77.3) | (80.2) | (33.9) | (28.1) | (77.3) | (28.1) | |||
Other comprehensive loss | 9.2 | (40) | (7.3) | (26) | (46.3) | (5.8) | |||||
Balance at the end of the period | (115.4) | (124.6) | (84.6) | (106.2) | (80.2) | (33.9) | (115.4) | (106.2) | |||
Accumulated Earnings (Deficit) | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | (7,824.5) | (7,833.1) | (7,597.6) | (7,083) | (6,961.4) | (6,624) | (7,597.6) | (6,624) | |||
Net earnings (loss) | 12.3 | 8.6 | (235.5) | (226.9) | (121.6) | (337.4) | |||||
Balance at the end of the period | (7,812.2) | (7,824.5) | (7,833.1) | (7,309.9) | (7,083) | (6,961.4) | (7,812.2) | (7,309.9) | |||
Class A common stock | Common Stock | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance at the beginning of the period | $ 0.5 | $ 0.5 | $ 0.5 | $ 0.6 | $ 0.6 | $ 0.5 | $ 0.5 | $ 0.5 | |||
Balance (in shares) | 51,919,238 | 51,919,238 | 51,683,892 | 51,682,060 | 51,682,060 | 51,397,910 | 51,683,892 | 51,397,910 | |||
AMC Preferred Equity Unit conversion | $ 1 | ||||||||||
AMC Preferred Equity Unit conversion (in shares) | 99,540,642 | ||||||||||
Settlement payment | $ 0.1 | ||||||||||
Settlement payment (In shares) | 6,897,018 | ||||||||||
Share issuance | $ 0.4 | ||||||||||
Share issuance (in shares) | 40,000,000 | ||||||||||
Stock-based compensation | $ 0.1 | ||||||||||
Stock-based compensation (in shares) | 235,346 | 284,150 | |||||||||
Balance at the end of the period | $ 2 | $ 0.5 | $ 0.5 | $ 0.6 | $ 0.6 | $ 0.6 | $ 2 | $ 0.6 | |||
Balance (in shares) | 198,356,898 | 51,919,238 | 51,919,238 | 51,682,060 | 51,682,060 | 51,682,060 | 198,356,898 | 51,682,060 | |||
Series A Convertible Participating Preferred Stock | Preferred Stock | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance (in shares) | 9,954,065 | 9,741,909 | 7,245,872 | 5,168,206 | 5,168,206 | 5,139,791 | 7,245,872 | 5,139,791 | |||
AMC Preferred Equity Unit conversion (in shares) | (9,954,065) | ||||||||||
Share issuance (in shares) | 212,156 | 492,880 | 27,000 | ||||||||
Stock-based compensation (in shares) | 26,944 | 28,415 | |||||||||
Balance (in shares) | 9,954,065 | 9,741,909 | 5,195,206 | 5,168,206 | 5,168,206 | 5,195,206 | |||||
Series A Convertible Participating Preferred Stock | Preferred Stock | Forward purchase agreement | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance (in shares) | 1,976,213 | ||||||||||
AMC Preferred Stock Depository Shares | Preferred Stock | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Balance (in shares) | 99,540,642 | 97,419,080 | 72,458,706 | 51,682,060 | 51,682,060 | 51,397,910 | 72,458,706 | 51,397,910 | |||
AMC Preferred Equity Unit conversion (in shares) | (99,540,642) | ||||||||||
Share issuance (in shares) | 2,121,562 | 4,928,800 | 270,000 | ||||||||
Stock-based compensation (in shares) | 269,444 | 284,150 | |||||||||
Balance (in shares) | 99,540,642 | 97,419,080 | 51,952,060 | 51,682,060 | 51,682,060 | 51,952,060 | |||||
AMC Preferred Stock Depository Shares | Preferred Stock | Forward purchase agreement | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance (in shares) | 19,762,130 | ||||||||||
AMC Preferred Equity Units | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Net proceeds from AMC Preferred Equity Units issuance | $ 75.1 | $ 75.1 | |||||||||
AMC Preferred Equity Units | Second Lien Notes due 2026 | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Share issuance (in shares) | 19,762,130 | ||||||||||
AMC Preferred Equity Units | Board of Directors | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||
Shares awarded | 15,370 | 4,165 | |||||||||
RSUs and PSUs vested | 254,074 | 279,985 |
INCOME TAXES - narrative (Detai
INCOME TAXES - narrative (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
INCOME TAXES | ||
Effective income tax rate (as a percent) | (2.20%) | |
Net deferred tax liabilities | $ 32.8 | $ 32.1 |
FAIR VALUE MEASUREMENTS - Fair
FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details) $ in Millions | Sep. 30, 2023 USD ($) Y $ / shares |
Price Volatility Rate | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Estimates to value Warrants | 114.9 |
Discount yield | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Estimates to value Warrants | 4.8 |
Expected Term | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Estimates to value Warrants | Y | 3.5 |
Exercise Price | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Estimates to value Warrants | $ / shares | 1.068 |
Recurring basis | |
Other long-term assets: | |
Total assets at fair value | $ 10.8 |
Recurring basis | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Investments measured at net asset value | 3.8 |
Recurring basis | Hycroft | |
Other long-term assets: | |
The company's recorded investment | 7 |
Recurring basis | Quoted prices in active market (Level 1) | |
Other long-term assets: | |
Total assets at fair value | 7 |
Recurring basis | Quoted prices in active market (Level 1) | Hycroft | |
Other long-term assets: | |
The company's recorded investment | 7 |
Recurring basis | Significant unobservable inputs (Level 3) | |
Other long-term assets: | |
Total assets at fair value | 3.8 |
Recurring basis | Significant unobservable inputs (Level 3) | Investment in Hycroft Mining Holding Corporation Warrants | |
Other long-term assets: | |
Investments measured at net asset value | $ 3.8 |
FAIR VALUE MEASUREMENTS - Fai_2
FAIR VALUE MEASUREMENTS - Fair value on a nonrecurring basis (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Other Fair Value Measurement Disclosures | ||
Current maturities of corporate borrowings, carrying value | $ 20 | $ 20 |
Corporate borrowings, noncurrent, carrying value | 4,750.4 | $ 5,120.8 |
Total Carrying Value | ||
Other Fair Value Measurement Disclosures | ||
Current maturities of corporate borrowings, carrying value | 20 | |
Corporate borrowings, noncurrent, carrying value | 4,750.4 | |
Significant other observable inputs (Level 2) | ||
Other Fair Value Measurement Disclosures | ||
Current maturities of corporate borrowings, fair value | 16.2 | |
Corporate borrowings, noncurrent, fair value | $ 3,542.5 |
OPERATING SEGMENTS (Details)
OPERATING SEGMENTS (Details) ر.س in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | |||||
Dec. 30, 2022 USD ($) | Dec. 30, 2022 SAR (ر.س) | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) segment | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
OPERATING SEGMENT | |||||||
Number of reportable segments | segment | 2 | ||||||
Financial information by reportable operating segment | |||||||
Revenues | $ 1,405.9 | $ 968.4 | $ 3,708.2 | $ 2,920.5 | |||
Adjusted EBITDA | 193.7 | (12.9) | 383.3 | 32.1 | |||
Capital expenditures | 57.5 | 54.5 | 153.5 | 129.7 | |||
Long-term assets, net | 7,813 | 7,813 | $ 8,233.5 | ||||
SCC | |||||||
OPERATING SEGMENT | |||||||
Equity method investment, amount sold | $ 30 | ر.س 112.5 | |||||
Financial information by reportable operating segment | |||||||
Percentage of equity method investment sold | 10% | 10% | |||||
U. S. markets | |||||||
Financial information by reportable operating segment | |||||||
Revenues | 1,063.9 | 753.3 | 2,855.8 | 2,224.3 | |||
Adjusted EBITDA | 150.6 | 1.2 | 336.3 | 52.2 | |||
U. S. markets | Operating Segments | |||||||
Financial information by reportable operating segment | |||||||
Capital expenditures | 40.8 | 40.1 | 112.2 | 91.5 | |||
Long-term assets, net | 5,854.1 | 5,854.1 | 6,135.9 | ||||
International markets. | |||||||
Financial information by reportable operating segment | |||||||
Revenues | 342 | 215.1 | 852.4 | 696.2 | |||
Adjusted EBITDA | 43.1 | (14.1) | 47 | (20.1) | |||
International markets. | Operating Segments | |||||||
Financial information by reportable operating segment | |||||||
Capital expenditures | 16.7 | $ 14.4 | 41.3 | $ 38.2 | |||
Long-term assets, net | $ 1,958.9 | $ 1,958.9 | $ 2,097.6 |
OPERATING SEGMENTS - Reconcilia
OPERATING SEGMENTS - Reconciliation (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
OPERATING SEGMENT | ||||||||
Net Income (Loss) | $ 12.3 | $ 8.6 | $ (235.5) | $ (226.9) | $ (121.6) | $ (337.4) | $ (214.6) | $ (685.9) |
Income tax provision | 2.3 | 1.8 | 4.6 | 2.5 | ||||
Interest expense | 103.7 | 95.7 | 307.4 | 278.4 | ||||
Depreciation and amortization | 88.7 | 96.9 | 279.1 | 293 | ||||
Certain operating expense | 3.8 | 4.3 | 4 | 10.5 | ||||
Equity in (earnings) loss of non-consolidated entities | (3.1) | (2.8) | (5.3) | 3.3 | ||||
Cash distributions from non-consolidated entities | 2.2 | 3.4 | 3.9 | 5 | ||||
Attributable EBITDA | 1.4 | 0.1 | 1.6 | 0.1 | ||||
Investment expense (income) | (3) | 18.3 | (11.4) | 12.2 | ||||
Other expense (income) | (14.1) | 6.2 | (1.4) | 110.9 | ||||
Other non-cash rent benefit | (8.4) | (6.6) | (27) | (20.6) | ||||
General and administrative - unallocated: | ||||||||
Merger, acquisition and other costs | 0.7 | 0.3 | 1.5 | 0.4 | ||||
Stock-based compensation expense | 7.2 | (3.6) | 40.9 | 22.3 | ||||
Adjusted EBITDA | 193.7 | (12.9) | 383.3 | 32.1 | ||||
(Gain) loss on extinguishment of debt | (97.5) | 96.4 | ||||||
Interest income | 3.7 | 8.5 | ||||||
Shareholder litigation | (16.1) | 99.3 | ||||||
Hycroft | ||||||||
OPERATING SEGMENT | ||||||||
Decrease (increase) in fair value of investments | (0.1) | 11.8 | 5.4 | 10.8 | ||||
Increase (decrease) in fair value of investment in warrants | (0.8) | (7.7) | 7.4 | |||||
General and administrative - unallocated: | ||||||||
Interest income | 2.8 | 3.3 | ||||||
Investment in Hycroft Mining Holding Corporation Warrants | ||||||||
OPERATING SEGMENT | ||||||||
Increase (decrease) in fair value of investment in warrants | (5.4) | |||||||
NCM | ||||||||
OPERATING SEGMENT | ||||||||
Decrease (increase) in fair value of investments | 1.6 | |||||||
Decline in estimated fair value of investment | 1.8 | 11.1 | ||||||
Attributable EBITDA | ||||||||
OPERATING SEGMENT | ||||||||
Income tax provision | 0.1 | 0.1 | (0.1) | 0.1 | ||||
Interest expense | 0.1 | 0.2 | ||||||
Depreciation and amortization | 0.4 | 0.7 | 1 | 2 | ||||
Equity in (earnings) loss of non-consolidated entities | (3.1) | (2.8) | (5.3) | 3.3 | ||||
Equity in (earnings) of non-consolidated entities excluding International theatre joint ventures | (2.1) | (3.5) | (4.7) | (3.1) | ||||
Equity in earnings (loss) of International theatre joint ventures | 1 | (0.7) | 0.6 | (6.4) | ||||
Impairment of long-lived assets | 4.2 | |||||||
Attributable EBITDA | 1.4 | 0.1 | 1.6 | 0.1 | ||||
Investment expense (income) | 0.2 | 0.1 | (0.2) | |||||
Other expense (income) | ||||||||
General and administrative - unallocated: | ||||||||
(Gain) loss on extinguishment of debt | (10.8) | (97.5) | 96.4 | |||||
Foreign currency transaction (gains) losses | $ 12.8 | $ 6.3 | (3.2) | $ 14.7 | ||||
SCC | ||||||||
General and administrative - unallocated: | ||||||||
Gain on divestment of equity method investment | $ (15.5) |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended | |||||||||||||
Aug. 24, 2023 | Aug. 11, 2023 | Jun. 14, 2023 USD ($) | May 04, 2023 USD ($) item | Apr. 02, 2023 | Feb. 20, 2023 item | Jan. 06, 2023 USD ($) | Nov. 30, 2022 USD ($) | Jun. 06, 2022 USD ($) | Sep. 02, 2021 USD ($) | Sep. 30, 2023 USD ($) item | Sep. 30, 2023 USD ($) item | Sep. 14, 2018 $ / shares | Jan. 19, 2018 item | Jan. 12, 2018 item | |
Commitments and contingencies line items | |||||||||||||||
Number of actions | item | 2 | ||||||||||||||
Number of pending actions | item | 2 | 2 | 2 | 2 | |||||||||||
Litigation settlement amount | $ 1 | $ 18 | |||||||||||||
Amount received from legal settlement | $ 14 | $ 17.4 | |||||||||||||
Fee and expense award to Plaintiff's counsel | $ 3.4 | $ 99.3 | |||||||||||||
Dividends declared | $ / shares | $ 1.55 | ||||||||||||||
Stock split conversion ratio | 0.1 | ||||||||||||||
Shareholder litigation | $ (16.1) | 99.3 | |||||||||||||
Number of insurers against whom lawsuit filed | item | 17 | ||||||||||||||
Excess amount deductible | $ 10 | ||||||||||||||
Excess amount paid by the primary insurer | $ 5 | ||||||||||||||
Shareholder Litigation | |||||||||||||||
Commitments and contingencies line items | |||||||||||||||
Stock split conversion ratio | 0.1333 | 0.1333 | |||||||||||||
Shareholder litigation | 110.1 | ||||||||||||||
Litigation contingency reserve charge | 99.3 | 99.3 | |||||||||||||
Insurance Settlements Receivable | $ 10.8 | $ 10.8 |
EARNINGS (LOSS) PER SHARE (Deta
EARNINGS (LOSS) PER SHARE (Details) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended | |||||||
Aug. 24, 2023 | Sep. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) | Mar. 31, 2023 USD ($) | Sep. 30, 2022 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) | Mar. 31, 2022 USD ($) | Sep. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) $ / shares shares | |
Earnings per share | |||||||||
Stock split conversion ratio | 0.1 | ||||||||
Conversion ratio | 0.1 | ||||||||
Numerator: | |||||||||
Net Income (Loss) | $ | $ 12.3 | $ 8.6 | $ (235.5) | $ (226.9) | $ (121.6) | $ (337.4) | $ (214.6) | $ (685.9) | |
Net earnings (loss) for diluted earnings (loss) per share | $ | $ 12.3 | $ (226.9) | $ (214.6) | $ (685.9) | |||||
Denominator (shares in thousands): | |||||||||
Weighted average shares for basic earnings (loss) per common share | 162,424,000 | 103,369,000 | 150,465,000 | 103,306,000 | |||||
Common equivalent shares for RSUs and PSUs | 183,000 | ||||||||
Weighted average shares for diluted earnings (loss) per common share | 162,607,000 | 103,369,000 | 150,465,000 | 103,306,000 | |||||
Basic earnings (loss) per common share (in dollars per share) | $ / shares | $ 0.08 | $ (2.20) | $ (1.43) | $ (6.64) | |||||
Diluted earnings (loss) per common share (in dollars per share) | $ / shares | $ 0.08 | $ (2.20) | $ (1.43) | $ (6.64) | |||||
Restricted stock unit | |||||||||
Denominator (shares in thousands): | |||||||||
Anti-dilutive securities not included in the computations of diluted earnings (loss) per share (in shares) | 467,353 | 542,815 | 548,419 | 542,815 | |||||
Performance Vesting | |||||||||
Denominator (shares in thousands): | |||||||||
Anti-dilutive securities not included in the computations of diluted earnings (loss) per share (in shares) | 192,052 | 283,809 | 294,251 | 283,809 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||||||||
Net Income (Loss) | $ 12.3 | $ 8.6 | $ (235.5) | $ (226.9) | $ (121.6) | $ (337.4) | $ (214.6) | $ (685.9) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Sep. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |